{"study_id": 49993, "supplement_id": 1523, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify the cause of wilt disease in Roselle plants and assess the correlation between plant age and resistance to Ralstonia solanacearum infection.", "results_summary": "The study identified Ralstonia solanacearum as the pathogen causing wilt disease in Roselle seedlings, with resistance increasing as plants aged. Disease incidence decreased from 75% in 2-week-old plants to 12.5% in 5-week-old plants.", "population_specificity": "Roselle plants (cultivar Chiada 1) and other species (tomato, pepper, eggplant) for pathogenicity testing.", "effective_dosage": "Bacterial suspension (about 10^8 CFU/ml) applied via soil drenching (30 ml per plant).", "study_duration": "Observations made 4-6 days post-inoculation; age correlation study involved plants aged 2-5 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:27.590425+00:00"}
{"study_id": 49997, "supplement_id": 1523, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the in vitro antibacterial effects of roselle calyx extract and protocatechuic acid against methicillin-resistant Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii.", "results_summary": "Both roselle calyx extract and protocatechuic acid effectively inhibited the growth of all tested bacterial pathogens, with protocatechuic acid showing significantly greater antibacterial activity. The antibacterial effects were heat-tolerant and concentration-dependent, though protocatechuic acid was less effective in human plasma than in broth.", "population_specificity": "In vitro bacterial cultures (not human subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:29.939262+00:00"}
{"study_id": 49999, "supplement_id": 1523, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of roselle juice consumption on urine composition in healthy men to assess its potential for treating and preventing renal stone disease.", "results_summary": "Roselle juice consumption led to decreased urinary excretion of creatinine, uric acid, citrate, tartrate, calcium, sodium, potassium, and phosphate, but not oxalate. A low dose (16 g/day) was more effective in reducing salt output than a high dose (24 g/day).", "population_specificity": "Thirty-six healthy men.", "effective_dosage": "16 g/day and 24 g/day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:33.827053+00:00"}
{"study_id": 49998, "supplement_id": 1523, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the antimutagenic and chemopreventive effects of Roselle (Hibiscus sabdariffa Linn.) extract in a colon carcinogenesis model.", "results_summary": "The Roselle extract showed significant antimutagenic activity against multiple carcinogens, reducing mutagenicity by 60-90% and decreasing aberrant crypt foci (ACF) formation in the initiation stage by 17-25%. However, it increased ACF formation in the post-initiation stage.", "population_specificity": "F344 rats in a colon carcinogenesis model.", "effective_dosage": "12.5 mg/plate (in vitro), 1.0 g/kg body weight (in vivo).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:34.045289+00:00"}
{"study_id": 36904, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the efficacy of rosemary oil and other herbal alternatives for managing androgenetic alopecia.", "results_summary": "The abstract suggests rosemary oil has gained popularity as a natural alternative for androgenetic alopecia, but it does not provide specific efficacy results. The review summarizes clinical studies on various herbal remedies, indicating a need for further research to establish concrete efficacy.", "population_specificity": "Genetically predisposed individuals with androgenetic alopecia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:34.535428+00:00"}
{"study_id": 36906, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of rosemary oil on oxidative stress markers, insulin, and glucose levels in streptozotocin-induced diabetic rats.", "results_summary": "Rosemary oil significantly reduced malondialdehyde (MDA) levels and increased glutathione (GSH) and superoxide dismutase (SOD) levels in diabetic rats. It also improved insulin and glucose levels compared to untreated diabetic rats.", "population_specificity": "Streptozotocin-induced diabetic rats.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:35.999286+00:00"}
{"study_id": 36907, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Rosemary oil in enhancing the anti-HIV-1 activity and controlled delivery of Atazanavir (ATV) through a self-nanoemulsifying drug delivery system (SNEDDS).", "results_summary": "The study found that ATV-SNEDDS with Rosemary oil inhibited HIV-1 infection at lower concentrations compared to pure ATV, suggesting improved efficacy and controlled delivery. Rosemary oil also showed potential in reducing adverse reactions associated with ATV.", "population_specificity": "Patients on antiretroviral therapy for HIV-1 infection (in vitro cell-based experiments).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:36.510132+00:00"}
{"study_id": 36908, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a nanoemulgel containing Timur oil and rosemary oil and evaluate its antifungal effects against Candida albicans.", "results_summary": "The nanoemulgel showed a zone of inhibition of 15 \u00b1 2.45 mm, outperforming the 1% ketoconazole cream (13 \u00b1 2.13 mm), and demonstrated sustained drug release (70 \u00b1 0.289% over 24 h) and high skin permeation (79.11 \u00b1 0.319%).", "population_specificity": "In vitro study targeting Candida albicans.", "effective_dosage": "Not specified.", "study_duration": "24-hour evaluation period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:37.455911+00:00"}
{"study_id": 36909, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antimicrobial efficacy of rosemary oil (RO) against selected Gram-negative and Gram-positive bacteria and its potential as a natural preservative in meat products.", "results_summary": "Rosemary oil showed antimicrobial effects, with a minimum inhibitory concentration of 2.5% against L. monocytogenes and S. aureus, and was most effective in inhibiting Salmonella and E. coli growth in meat samples compared to other treatments.", "population_specificity": "Beef pastes prepared from New Zealand commercial breed (3% fat) and wagyu (12% fat) beef tenderloins.", "effective_dosage": "2.5% (minimum inhibitory concentration)", "study_duration": "16 days of refrigerated storage", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:39.024186+00:00"}
{"study_id": 36912, "supplement_id": 1524, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the clinical efficacy of rosemary oil in treating androgenetic alopecia (AGA) and compare its effects with minoxidil 2%.", "results_summary": "Both rosemary oil and minoxidil 2% significantly increased hair count after 6 months, with no significant difference between the two treatments. Scalp itching increased in both groups but was more frequent with minoxidil.", "population_specificity": "Patients with androgenetic alopecia (AGA).", "effective_dosage": "Not specified.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:42.055752+00:00"}
{"study_id": 36911, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether rosemary oil (RO) protects against heat stress-induced damage in spermatozoa production, testicular structures, apoptosis, and androgenic receptor function in growing Japanese quail.", "results_summary": "Rosemary oil supplementation alleviated heat stress-induced negative effects, including reduced lipid peroxidation, improved spermatogenic cell counts, restored Bcl-2 and AR levels, and mitigated histopathologic damage. The study demonstrated RO's protective role against heat stress in quail reproductive health.", "population_specificity": "Male Japanese quail chicks (15 days old) subjected to heat stress conditions.", "effective_dosage": "125 ppm and 250 ppm dietary supplementation.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:43.376365+00:00"}
{"study_id": 36913, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antimicrobial efficacy of rosemary oil embedded in microcellular foam starch (MFS) sachets against Listeria monocytogenes, lactic acid bacteria (LAB), and total aerobic bacteria (TAB) in shredded mozzarella cheese.", "results_summary": "Rosemary oil volatiles reduced L. monocytogenes by 2.5 log CFU/g after 9 days and inhibited LAB and TAB growth by 1.2 and 1.4 log CFU/g, respectively, after 15 days. However, the treatment produced an unfavorable odor.", "population_specificity": "Shredded mozzarella cheese inoculated with L. monocytogenes.", "effective_dosage": "Not specified (various concentrations tested).", "study_duration": "15 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:45.565628+00:00"}
{"study_id": 36916, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of rosemary oil on freshness indicators, oxidative stability, fatty acid content, and biogenic amine levels in minced rainbow trout muscle during storage.", "results_summary": "Rosemary oil improved pH, oxidative stability, and fatty acid profile, extending shelf-life. It also reduced biogenic amine content, particularly putrescine, cadaverine, tyramine, and histamine, while terpenoid presence enhanced food quality.", "population_specificity": "Minced rainbow trout muscle (MTM) stored at 4 \u00b1 1 \u00b0C.", "effective_dosage": "0.2%, 1%, and 3% concentrations of rosemary oil.", "study_duration": "Three and nine days of storage.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:46.376835+00:00"}
{"study_id": 36915, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of rosemary oil, alone and in combination with chitosan, in extending the shelf-life and preserving the taste of vacuum-packed fresh turkey meat.", "results_summary": "Rosemary oil (0.25% v/w) extended the shelf-life of turkey meat by 7-8 days compared to the control, and its combination with chitosan further extended shelf-life by over 11 days. Taste scores were not negatively affected by the treatments.", "population_specificity": "Fresh turkey meat stored under vacuum packaging at 2\u00b0C.", "effective_dosage": "0.25% v/w rosemary oil.", "study_duration": "Up to 21 days of storage.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:46.573590+00:00"}
{"study_id": 49991, "supplement_id": 1523, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of Roselle (Hibiscus sabdariffa L.) in maintaining cultured murine bone marrow-derived hematopoietic stem cells (HSCs) and its potential as a genoprotectant against oxidative damage.", "results_summary": "Roselle enhanced the survival of bone marrow cells (BMCs) and HSCs, increased glutathione (GSH) levels and superoxide dismutase (SOD) activity, and showed genoprotective effects against H2O2-induced DNA damage, without affecting reactive oxygen species (ROS) levels.", "population_specificity": "Murine (mouse) bone marrow-derived hematopoietic stem cells (HSCs).", "effective_dosage": "500 and 1000 ng/mL for 24 hours.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:47.235555+00:00"}
{"study_id": 48642, "supplement_id": 1525, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Rosmarinic Acid (RA) could ameliorate folic acid-induced renal injury in mice by modulating the SIRT1/NOX1 pathway and reducing oxidative stress.", "results_summary": "RA significantly reduced blood urea nitrogen (BUN) and creatinine levels, improved histopathological damage, increased SIRT1 expression and antioxidant levels (GSH, SOD), and decreased NOX1 expression and oxidative stress (MDA) in mice with renal injury.", "population_specificity": "Male C57/BL6 mice (n=36, divided into 6 groups of 6).", "effective_dosage": "50 mg/kg and 100 mg/kg (FA + RA 50 and FA + RA 100 groups).", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:48.593240+00:00"}
{"study_id": 48643, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anticancer and anti-metastatic effects of rosmarinic acid (RA) in gastric cancer AGS cells, including its mechanisms of action.", "results_summary": "RA suppressed AGS cell growth by inducing apoptosis via caspase mediation and inhibited metastasis by modulating epithelial-mesenchymal transition (EMT) biomarkers. It also inactivated the STAT3, AKT, and ERK1/2 pathways and notably inhibited in vivo tumor growth.", "population_specificity": "Gastric cancer AGS cells (in vitro and in vivo).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:50.463498+00:00"}
{"study_id": 48644, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antiviral capacity and potential mechanisms of Rosmarinic Acid (RA) in inhibiting Japanese encephalitis virus (JEV)-induced inflammation and replication in vitro.", "results_summary": "RA significantly inhibited JEV replication and suppressed the expression of inflammatory cytokines (IL-6, IL-1\u03b2, TNF-\u03b1, CCL-2) in JEV-infected BV-2 cells in a dose-dependent manner. It also downregulated RIG-I and p62 expression, which contributed to reduced neuroinflammation.", "population_specificity": "JEV-infected BV-2 microglial cells (in vitro study).", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:52.556540+00:00"}
{"study_id": 48645, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the molecular mechanisms of rosmarinic acid's antioxidant and anticancer properties and its potential applications in cancer prevention and therapy.", "results_summary": "The study found that rosmarinic acid inhibits tumor cell proliferation, induces apoptosis, and prevents metastasis in various cancers through multiple mechanisms, including its antioxidant effects, though bioavailability challenges limit its therapeutic efficacy.", "population_specificity": "Not specified (in vitro, in vivo, and in silico studies reviewed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:53.344410+00:00"}
{"study_id": 48646, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the mechanisms of action of rosmarinic acid in gastrointestinal cancers.", "results_summary": "The study highlights rosmarinic acid's potential anti-carcinogenic, anti-inflammatory, and anti-oxidative properties, suggesting its positive effects in treating gastrointestinal cancers such as oral, stomach, pancreas, colon, and liver cancers.", "population_specificity": "Gastrointestinal cancer patients (oral, stomach, pancreas, colon, liver).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:53.930296+00:00"}
{"study_id": 48648, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of Rosmarinic Acid on osteoarthritis progression and cartilage regeneration in animal models.", "results_summary": "Rosmarinic Acid suppressed catabolic factors and the NF-\u03baB signaling pathway, protected against cartilage degradation, and promoted the expression of anabolic factors like Sox9, Col2a1, and Acan in vitro, ex vivo, and in vivo.", "population_specificity": "DMM-induced osteoarthritis mouse model and chondrocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:54.754948+00:00"}
{"study_id": 48647, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether rosmarinic acid (RA) improves the immediate microtensile bond strength (\u00b5TBS) of a self-etch adhesive to artificial caries-affected dentine, with or without sodium hypochlorite (NaOCl) treatment.", "results_summary": "RA significantly increased \u00b5TBS in both the NaOClRA and RA groups compared to the NaOCl and control groups, demonstrating its effectiveness in enhancing bond strength to caries-affected dentine. The combination of NaOCl and RA (NaOClRA group) showed the highest improvement in \u00b5TBS.", "population_specificity": "Dentine surfaces of 60 extracted human premolars subjected to artificial caries induction.", "effective_dosage": "Not specified (RA solution concentration not detailed).", "study_duration": "24 hours of water storage post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:12:56.340856+00:00"}
{"study_id": 48649, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to elucidate the anticancer effects of Rosmarinic Acid (RA) in glioblastoma (GB) cells and investigate its underlying mechanisms, including its impact on the SIRT1/FOXO1/NF-\u03baB axis and PTEN/PI3K/AKT pathway.", "results_summary": "RA demonstrated anti-proliferative, pro-apoptotic, and anti-angiogenic effects in both 2D and 3D glioblastoma cell cultures, suppressed EMT and CSC-like properties, and outperformed temozolomide (TMZ) at lower doses. Its effects were mediated through downregulation of the SIRT1/FOXO1/NF-\u03baB axis and inhibition of PTEN/PI3K/AKT signaling, though ERK activation paradoxically required blocking for optimal efficacy.", "population_specificity": "Human glioblastoma cell lines (U-87MG and LN229) in 2D and 3D cultures.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:00.020328+00:00"}
{"study_id": 48650, "supplement_id": 1525, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore the antiallodynic effects of rosmarinic acid in a neuropathic pain model and assess the involvement of adrenergic and opioidergic mechanisms.", "results_summary": "Rosmarinic acid demonstrated a statistically significant antiallodynic effect, comparable to pregabalin, mediated primarily by \u03b12-adrenergic and opioid receptor stimulation. The effect was independent of locomotor activity and showed dose-dependent efficacy.", "population_specificity": "Chronic constriction injury-induced neuropathic pain model (animal study).", "effective_dosage": "10, 20, and 40 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:00.301816+00:00"}
{"study_id": 48653, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective effect of rosmarinic acid (RA) on radiation-induced pulmonary fibrosis (RIPF) in mice and explore its mechanism of action.", "results_summary": "RA showed antifibrotic effects in RIPF model mice by inhibiting fibroblast-to-myofibroblast transformation (FMT) through exosomes derived from lung epithelial cells. It reduced transcription and translation efficiency of sphingosine kinase 1 and suppressed glycolysis-triggered FMT via PFKFB3 acetylation regulation.", "population_specificity": "Mice with radiation-induced pulmonary fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:01.777841+00:00"}
{"study_id": 48652, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Rosmarinic Acid (RA) inhibits the silencing effect of miR-30a-5p on the BCL2L11 gene and promotes apoptosis in breast cancer stem-like cells (BCSCs).", "results_summary": "RA inhibited migration, colony formation, and viability of BCSCs, induced cell cycle arrest in the G0-G1 phase, and enhanced apoptosis. It also downregulated miR-30a-5p expression, with BCL2L11 identified as a direct target of miR-30a-5p.", "population_specificity": "MDA-MB-231 induced breast cancer stem-like cells (BCSCs).", "effective_dosage": "100 \u03bcg/mL and 200 \u03bcg/mL RA.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:02.291276+00:00"}
{"study_id": 48655, "supplement_id": 1525, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Rosmarinic Acid (RA) as a complementary therapy in cancer treatment, focusing on its ability to reverse chemoresistance and mitigate toxicity from chemotherapy and radiotherapy.", "results_summary": "RA demonstrated potential to reverse cancer resistance to first-line chemotherapeutics and showed protective effects against chemotherapy- and radiotherapy-induced toxicity, primarily due to its antioxidant properties. The review compiled evidence from 56 articles, suggesting RA's beneficial role in cancer treatment.", "population_specificity": "Not specified (general cancer treatment context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:02.678598+00:00"}
{"study_id": 48654, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the anti-inflammatory and antioxidant properties of RosA-CrFe2O4 nanoparticles in LPS-induced macrophages.", "results_summary": "The study found that RosA-CrFe2O4 nanoparticles exhibited moderate antioxidant effects (IC50 of 59.61\u00b14.52\u03bcg/ml) and effectively suppressed pro-inflammatory gene expression (IL-1\u03b2, TNF-\u03b1, IL-6, iNOS) and cytokine release (IL-6, TNF-\u03b1) in LPS-stimulated macrophages.", "population_specificity": "LPS-stimulated raw 264.7 macrophages (in vitro study).", "effective_dosage": "Not specified (IC50 value provided for antioxidant activity).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:03.464381+00:00"}
{"study_id": 48656, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of rosmarinic acid (RA) on apoptosis induction in melanoma cells, modulation of purinergic signaling (CD39, CD73, A2A), and cytokine levels.", "results_summary": "RA induced apoptosis in melanoma cells, downregulated CD73 and A2A expression (especially at high concentrations), and increased levels of IL-6, IL-4, IL-10, IFN-\u03b3, and TNF-\u03b1. The study suggests RA's potential for targeting immune suppression in melanoma.", "population_specificity": "SK-MEL-28 melanoma cells (in vitro study)", "effective_dosage": "Different concentrations (specific amounts not stated)", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:05.581501+00:00"}
{"study_id": 36914, "supplement_id": 1524, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of rosemary oil inhalation on nervous system activity, physiological parameters, and mood states in human subjects.", "results_summary": "Rosemary oil inhalation significantly increased blood pressure, heart rate, and respiratory rate, while EEG analysis showed reduced alpha wave power and increased beta wave power in the anterior brain region. Subjects reported feeling more active and \"fresher\" after treatment.", "population_specificity": "Twenty healthy volunteers.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:08.503261+00:00"}
{"study_id": 48659, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antioxidant and anti-inflammatory effects of rosmarinic acid (RA) in a rat model of ovalbumin-induced asthma.", "results_summary": "RA significantly reduced lung inflammation, oxidative stress markers (malondialdehyde, nitrite), and improved antioxidant levels (thiol, catalase, superoxide dismutase activity) compared to untreated asthmatic rats. It also lessened lung pathological changes, demonstrating efficacy comparable to dexamethasone in some measures.", "population_specificity": "Ovalbumin-induced asthmatic rats", "effective_dosage": "0.5, 1, and 2 mg/kg", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:10.215024+00:00"}
{"study_id": 48660, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether rosmarinic acid exhibits inhibitory effects on the SARS-CoV-2 main protease (Mpro) and to elucidate its molecular mechanism of action.", "results_summary": "The study found that rosmarinic acid significantly inhibits SARS-CoV-2 Mpro, and structural biology analysis revealed the precise crystal structure of the rosmarinic acid-Mpro complex, providing mechanistic insights for antiviral drug development.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:10.409230+00:00"}
{"study_id": 48658, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the neuroprotective effects of Rosmarinic acid (RosA) encapsulated in nanoliposomes (RosA-LIP) on ischemic stroke, focusing on its ability to mitigate ferroptosis and improve blood-brain barrier integrity.", "results_summary": "RosA-LIP enhanced stability and brain delivery, reduced behavioral and pathological damage, inhibited ferroptosis by improving mitochondrial function and lipid peroxidation markers, and modulated iron-related proteins (FPN1 and TfR1) to protect brain microvascular endothelial cells.", "population_specificity": "Wild-type and TfR1EC cKO mice subjected to dMCAO (ischemic stroke model).", "effective_dosage": "20 mg/kg/d, intraperitoneal injection.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:10.580976+00:00"}
{"study_id": 48661, "supplement_id": 1525, "safety_score": "30", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to clarify the mechanism by which Rosmarinic Acid (RA) induces metal-mediated oxidative DNA damage, focusing on its interaction with copper and NADH.", "results_summary": "RA plus Cu(II) significantly increased oxidative DNA damage (8-oxodG formation) and caused DNA strand breakage and base modification, particularly at thymine and cytosine residues. The damage was enhanced by NADH and involved H2O2, Cu(I), and ROS other than \u2022OH.", "population_specificity": "Isolated calf thymus DNA (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interaction with Cu(II) and NADH noted", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:11.856597+00:00"}
{"study_id": 48662, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether Rosmarinic Acid (RosA) could inhibit autophagy-regulated CD8+ T cells via the Ras/Raf/MEK/ERK signaling pathway in a Chlamydia trachomatis (CT)-infected mouse model.", "results_summary": "RosA attenuated pathological endometrial damage, reduced CD8+ T cell activation, and inhibited autophagy by activating the Ras/Raf/MEK/ERK pathway, showing comparable effects to the reference drug azithromycin. The MEK inhibitor cobimetinib reversed RosA's protective effects, confirming the pathway's role.", "population_specificity": "CT-infected female mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:12.901104+00:00"}
{"study_id": 48663, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential anti-Chikungunya virus (CHIKV) effects of rosmarinic acid using network pharmacology, molecular docking, and in vitro experiments.", "results_summary": "Rosmarinic acid was found to modulate the IL-17 signaling pathway, inhibiting CHIKV proliferation by 50% and reducing TNF-\u03b1 expression in infected 293T cells, improving cell survival.", "population_specificity": "In vitro model using 293T cells infected with CHIKV.", "effective_dosage": "60 \u03bcM", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:13.985585+00:00"}
{"study_id": 48664, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether rosmarinic acid (RA) attenuates indoxyl sulfate-induced renal fibrosis by regulating the NLRP3 inflammasome/IL-1\u03b2/Smad circuit.", "results_summary": "RA downregulated NLRP3 inflammasome activation and its downstream effectors (cleaved-caspase-1 and cleaved-IL-1\u03b2) in a dose-dependent manner, reduced ROS levels, and inhibited Smad-2/3 phosphorylation. RA and MCC950 synergistically suppressed UUO-induced NLRP3 signaling, suggesting potential for combinatory treatment of renal fibrosis.", "population_specificity": "Murine model (UUO mice) and NRK-52E cells.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:18.689412+00:00"}
{"study_id": 48666, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer effects of Rosmarinic Acid (RA) on brain tumors, focusing on its impact on oxidative stress, cell proliferation, and apoptosis.", "results_summary": "RA at 20 mg/kg reduced tumor volume, prolonged survival time, increased p53 and p21 mRNA expression, attenuated SOD and CAT activities, elevated caspase-3, and increased TUNEL-positive cells, indicating reduced tumor cell invasion.", "population_specificity": "Rats with implanted C6 glioma cells in the caudate nucleus.", "effective_dosage": "5, 10, and 20 mg/kg (intraperitoneal) administered daily.", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:19.625801+00:00"}
{"study_id": 48667, "supplement_id": 1525, "safety_score": "85", "efficacy_score": 88, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Nuvastatic\u2122 (containing Rosmarinic Acid) in improving cancer-related fatigue (CRF) among solid tumor patients undergoing chemotherapy.", "results_summary": "The Nuvastatic\u2122 group showed significant reductions in fatigue scores (BFI and VAS-F), improved quality of life, and lowered oxidative stress biomarkers compared to placebo, with minimal adverse events (vomiting, fever, headache).", "population_specificity": "110 solid malignant tumor patients (stage II-IV) undergoing chemotherapy.", "effective_dosage": "1000 mg thrice daily.", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:19.797209+00:00"}
{"study_id": 48657, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and evaluate rosmarinic acid-conjugated gelatin nanogels (DRGNG) for treating dry eye disease by simultaneously scavenging reactive oxygen species (ROS) and promoting mucin secretion.", "results_summary": "DRGNG effectively suppressed ROS production, reduced inflammatory factors, and promoted mucin secretion in vitro and in vivo, demonstrating improved therapeutic outcomes in both evaporative and aqueous deficient dry eye disease models compared to commercial treatments.", "population_specificity": "Preclinical models (in vitro and in vivo) of dry eye disease.", "effective_dosage": "Dosage halved compared to commercial Diquas\u00ae (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:20.513679+00:00"}
{"study_id": 48665, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a pH-responsive nano-valve (LIG-ROS-BMSN) loaded with Rosmarinic Acid for targeted chemotherapy against Hep-G2 and NCI-H460 cancer cell lines.", "results_summary": "The LIG-ROS-BMSN nano-valve demonstrated controlled pH-dependent release of Rosmarinic Acid, achieving significantly lower IC50 values (1.70 \u00b1 0.01 \u03bcg/mL and 3.25 \u00b1 0.14 \u03bcg/mL) against Hep-G2 and NCI-H460 cell lines compared to Rosmarinic Acid alone (14.0 \u00b1 0.7 \u03bcg/mL and 29.10 \u00b1 0.25 \u03bcg/mL). The nano-valve enhanced targeted chemotherapeutic response in mild acidic environments.", "population_specificity": "Hep-G2 and NCI-H460 cancer cell lines (in vitro study).", "effective_dosage": "Not specified (IC50 values provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:20.856538+00:00"}
{"study_id": 48669, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to systematically investigate the neuroprotective mechanisms of Rosmarinic Acid (RA) in delaying neurodegenerative diseases (NDs) using Caenorhabditis elegans models.", "results_summary": "RA significantly reduced oxidative stress, improved neural and protein homeostasis, and ameliorated mitochondrial dysfunction. It also prevented toxic protein aggregation and enhanced proteostasis, suggesting potential as a nutritional intervention for NDs.", "population_specificity": "Caenorhabditis elegans (nematode) models of neurodegenerative diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:21.516968+00:00"}
{"study_id": 48670, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to characterize the cellular response in kidneys to diabetic nephropathy (DN)-induced injury and evaluate the therapeutic effects of rosmarinic acid (RA) at single-cell levels.", "results_summary": "RA significantly alleviated renal tubular epithelial injury, particularly in the proximal tubular S1 segment and podocytes, while reducing macrophage inflammation, oxidative stress, and natural killer cell cytotoxicity. The findings suggest RA mitigates kidney damage, oxidative stress, and inflammation in DN.", "population_specificity": "Diabetic nephropathy (kidney damage due to diabetes).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:22.252237+00:00"}
{"study_id": 48668, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether rosmarinic acid (RA) combined with deferasirox (Dfe) could inhibit ferroptosis in renal tubular epithelial cells (RTECs) and attenuate crush syndrome-related acute kidney injury (CS-AKI).", "results_summary": "The study found that RA disrupted the Keap1-Nrf2 interaction, stabilized Nrf2, and promoted its nuclear translocation, exerting antioxidant effects. Combined with Dfe, RA effectively reversed myoglobin-induced ferroptosis in RTECs, improving kidney function in CS-AKI mice.", "population_specificity": "CS-AKI mouse model and in vitro TCMK1 and NRK-52E cells.", "effective_dosage": "10 \u03bcM RA (combined with 10 \u03bcM Dfe).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:22.571654+00:00"}
{"study_id": 48672, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop fibrous cellulose acetate materials loaded with rosmarinic acid (RA) and assess their properties, including RA release, antioxidant activity, and antifungal effects.", "results_summary": "The study found that adding polyethylene glycol (PEG) improved RA release (91% over 360 min vs. 53% without PEG) and enhanced hydrophilicity. Both RA-loaded materials exhibited high antioxidant activity, and CA/PEG/RA showed good antifungal activity against C. albicans.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified (release measured over 360 min)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:28.217830+00:00"}
{"study_id": 48674, "supplement_id": 1525, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to investigate the mechanism by which Rosmarinic Acid (RosA) alleviates allergic asthma via the gut-lung axis and its modulation of gut microbiota.", "results_summary": "RosA reduced cholate levels, decreased 5-HT synthesis, and increased SCFAs, improving intestinal integrity and reducing Th2/ILC2-mediated inflammation. It also inhibited LPS production, lowering pulmonary inflammation and oxidative stress.", "population_specificity": "Not specified (likely animal models based on methods described).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:28.490534+00:00"}
{"study_id": 48673, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to elucidate the molecular mechanism underlying rosmarinic acid (RA) synthesis in perilla leaves under high light stress and identify key regulatory genes involved in RA accumulation.", "results_summary": "High light stress upregulated genes involved in RA synthesis, particularly PfNAC2, PfGBF3, and PfC4H, which were found to co-express and regulate RA accumulation. Transient and stable overexpression of these genes significantly increased RA levels in perilla.", "population_specificity": "Perilla (Perilla frutescens (L.) Britt) leaves under high light conditions.", "effective_dosage": "Not specified", "study_duration": "1 and 48 hours of high light exposure", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:29.256408+00:00"}
{"study_id": 48677, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Rosmarinic Acid (RA) could improve acrylamide (ACR)-induced neurotoxicity and explore its potential mechanisms.", "results_summary": "RA pretreatment reversed ACR-induced neurological dysfunction in mice, prevented neuronal apoptosis, reduced inflammation by downregulating NF-\u03baB and TNF-\u03b1, inhibited NLRP3 inflammasome activation, and alleviated endoplasmic reticulum stress (ERS).", "population_specificity": "Mice exposed to ACR", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:29.759007+00:00"}
{"study_id": 48675, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the antifibrotic effects of rosmarinic acid (RA) and plant extracts containing RA in various experimental models.", "results_summary": "RA and plant extracts containing RA were found to attenuate fibrosis in multiple organs by reducing oxidative stress, inflammation, and fibrogenic gene expression while activating beneficial pathways like PPAR\u03b3, AMPK, and NRF2. The study suggests RA is a key active ingredient in Lamiaceae plants for antifibrotic effects.", "population_specificity": "Experimental animal models (liver, kidneys, heart, lungs, and abdomen).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:29.833879+00:00"}
{"study_id": 48678, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore whether Rosmarinic Acid (RA) could protect against cisplatin-induced acute kidney injury (AKI) in mice.", "results_summary": "RA treatment restored renal transmembrane transporter CTR1, reduced serum albumin and globulin levels, normalized serum electrolytes, and downregulated the nephrotoxicity biomarker KIM-1 in cisplatin-treated mice.", "population_specificity": "Mice with cisplatin-induced acute kidney injury.", "effective_dosage": "100 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:30.115914+00:00"}
{"study_id": 48676, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate plasma levels of Rosmarinic Acid (RA) after 12 weeks of supplementation and assess potential interactions between RA and antiretroviral drugs (efavirenz, darunavir, raltegravir).", "results_summary": "RA was detected in patients' plasma, primarily as sulphoglucuronide, and potential interactions with antiretroviral drugs were identified at the level of liver metabolizing enzymes and P-glycoprotein, suggesting RA may compete with these drugs in metabolism and distribution.", "population_specificity": "Patients infected with human immunodeficiency virus (HIV).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "Potential interactions with efavirenz, darunavir, and raltegravir due to competition in metabolism and distribution systems.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:30.245527+00:00"}
{"study_id": 48679, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of rosmarinic acid (RA) on the EGFR signaling pathway in ovarian adenocarcinoma cells (OVCAR3) in the presence of doxorubicin (DOX), focusing on its antitumor and antioxidant properties.", "results_summary": "RA and DOX inhibited OVCAR3 cell proliferation and induced apoptosis in a dose- and time-dependent manner. Western blot analysis showed downregulation of Bcl-2 and EGFR expression in OVCAR3 cells treated with RA and DOX.", "population_specificity": "Ovarian adenocarcinoma cell line (OVCAR3) and human skin keratinocyte cell line (HaCaT) as control.", "effective_dosage": "RA (IC50 = 437.6 \u03bcM), DOX (IC50 = 0.08 \u03bcM).", "study_duration": "72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:34.221172+00:00"}
{"study_id": 48682, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the chemoprotective properties of Rosmarinic Acid, particularly its effects on triple-negative breast cancer cell lines resistant to hormone therapy.", "results_summary": "Rosmarinic Acid demonstrated potent chemoprotective properties, influencing key cancer signaling pathways and potentially inhibiting tumor growth and metastasis in triple-negative breast cancer cell lines. The study highlights its potential as a natural anticancer agent through integrated chemical biology approaches.", "population_specificity": "Triple-negative breast cancer cell lines resistant to hormone therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:37.301388+00:00"}
{"study_id": 48681, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-allergic activity of Rosmarinic Acid (RA) on IgE-mediated anaphylaxis responses in mast cells and a passive cutaneous anaphylaxis (PCA) mice model.", "results_summary": "RA inhibited IgE-induced mast cell degranulation, reduced the release of key biomarkers (\u03b2-HEX and histamine), suppressed ROS overproduction and Ca2+ flux, and regulated genes involved in MAPK and oxidative stress pathways. It also significantly reduced allergic edema in PCA mice.", "population_specificity": "Rat basophilic leukemia (RBL)-2H3 mast cells and anti-DNP IgE/DNP-HSA stimulated mice.", "effective_dosage": "Dose-dependent (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:38.337319+00:00"}
{"study_id": 48684, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Rosmarinic Acid (RA) could protect against cardiotoxicity induced by electromagnetic radiation (EMR) in rats.", "results_summary": "RA significantly reversed oxidative stress markers (elevated TAC, GSH, SOD, CAT, GPx; reduced MDA, NO, PC) and improved cardiac markers in EMR-exposed rats, demonstrating protective effects against EMR-induced cardiotoxicity.", "population_specificity": "Male Wistar rats", "effective_dosage": "5 mg/kg (oral administration)", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:38.380283+00:00"}
{"study_id": 48680, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether rosmarinic acid (RA), either alone or encapsulated in exosomes, could attenuate LPS-induced endometritis and improve embryo implantation in mice.", "results_summary": "RA-loaded exosomes (RALExo10) and RA combined with exosomes (RA10 + Exo10) improved pathological changes, increased progesterone levels, enhanced implantation rates, and regulated inflammatory cytokines (TGF-\u03b2, IL-10, IL-15, IL-18) and gene expressions (LIF, MUC-16).", "population_specificity": "Female mice with LPS-induced endometritis.", "effective_dosage": "10 mg/kg of RA or exosomes, injected into the uterine horn.", "study_duration": "Single administration 24 hours after endometritis induction, followed by mating and assessment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:38.493250+00:00"}
{"study_id": 48685, "supplement_id": 1525, "safety_score": "30", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the toxicity of Rosmarinic Acid (RA) in human red blood cells (RBCs) and explore its molecular mechanisms related to hemolysis and eryptosis.", "results_summary": "RA caused concentration-dependent hemolysis and eryptosis, marked by phosphatidylserine exposure, calcium accumulation, and cell shrinkage. These effects were mediated through energy deprivation, p38 MAPK, protein kinase C, and casein kinase 1\u03b1, but some protective mechanisms were noted at sub-hemolytic concentrations.", "population_specificity": "RBCs isolated from healthy human donors.", "effective_dosage": "10-800 \u03bcM", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:39.033355+00:00"}
{"study_id": 48683, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to elucidate the cell signaling mechanisms underlying the antioxidant activity of Rosmarinic Acid (RA) and confirm its protective role against UVB-induced oxidative damage.", "results_summary": "RA enhanced GCLC and GSS expression, activated NRF2 signaling, and protected against UVB-induced oxidative damage, DNA damage, and apoptosis in human keratinocytes and mouse skin. The protective effects were mediated through AKT and ERK signaling pathways.", "population_specificity": "Human keratinocyte cell line (HaCaT) and SKH1 hairless mouse skin.", "effective_dosage": "Not specified (dose- and time-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:39.265816+00:00"}
{"study_id": 48686, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antidepressant effects and potential mechanisms of Rosmarinic Acid (RA) in mice with chronic CORT-induced depression-like behavior.", "results_summary": "RA treatment reduced depression-like behavior, improved hippocampal neurogenesis, and modulated glucocorticoid signaling and synaptic transduction via the BDNF/TrkB/PI3K pathway. It also reduced cell damage and apoptosis in vitro.", "population_specificity": "Male C57BL/6J mice and HT22 cells.", "effective_dosage": "10 or 20 mg/kg (mice); 12.5, 25, or 50 \u03bcM (HT22 cells).", "study_duration": "21 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:39.546215+00:00"}
{"study_id": 48689, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of rosmarinic acid on nasal mucosal healing in rats.", "results_summary": "Systemic rosmarinic acid administration significantly improved nasal mucosal healing, showing reduced inflammation and tissue damage compared to the control and local treatment groups. The systemic group exhibited the most pronounced benefits, likely due to anti-inflammatory effects.", "population_specificity": "Male adult Sprague Dawley albino rats.", "effective_dosage": "Not specified (applied locally or injected intraperitoneally once daily).", "study_duration": "15 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:45.438639+00:00"}
{"study_id": 48687, "supplement_id": 1525, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore the anti-allergic activities and underlying mechanisms of Rosmarinic Acid (RA) in ovalbumin (OVA)-induced intestinal allergic mice.", "results_summary": "RA effectively attenuated allergic reactions, reduced anaphylactic mediators, modulated immune responses (inhibiting Th2 cytokines while increasing Th1 and Treg cytokines), and regulated intestinal microbiota diversity in OVA-allergic mice.", "population_specificity": "Female BALB/c mice sensitized and challenged with OVA.", "effective_dosage": "30 mg/kg (low), 90 mg/kg (middle), and 270 mg/kg (high) RA interventions.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:46.606505+00:00"}
{"study_id": 48691, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of rosmarinic acid (combined with chitosan and TiO2) on preserving the quality attributes of rainbow trout fillets during cold storage.", "results_summary": "The CHTRA treatment (chitosan+TiO2+rosmarinic acid) showed lower bacterial counts and better color retention compared to the control, though differences between coating treatments were not significant. The TVB-N level in treatment groups remained below 20 mg/100 g by day 18, indicating slower spoilage.", "population_specificity": "Rainbow trout fillets (in vitro food preservation study).", "effective_dosage": "Not specified.", "study_duration": "18 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:47.686950+00:00"}
{"study_id": 48692, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Rosmarinic Acid (RosA) could protect against H1N1 virus-mediated lung injury and elucidate the underlying mechanisms.", "results_summary": "RosA effectively reduced H1N1-induced lung injury by attenuating inflammation, apoptosis, and cytotoxic T-cell recruitment, primarily through inhibition of NF-\u03baB and P38 MAPK pathways and activation of the h-PGDS-PGD2-HO-1 signal axis.", "population_specificity": "Mice infected with H1N1 virus (5LD50).", "effective_dosage": "Not specified (intragastric administration for 2 days).", "study_duration": "2 days pre-infection, assessed at day 7 post-infection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:48.136948+00:00"}
{"study_id": 48695, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the therapeutic potential of rosmarinic acid, encapsulated in nanoparticles within a pH/ROS dual-responsive hydrogel, for treating myocardial infarction by exerting anti-inflammatory, anti-apoptotic, and anti-fibrosis effects.", "results_summary": "The study found that rosmarinic acid, delivered via the hydrogel, effectively reduced inflammation, apoptosis, and fibrosis while promoting angiogenesis and restoring cardiac function in myocardial infarction models. The hydrogel also improved electrical signal transmission and cardiomyocyte synchronization.", "population_specificity": "In vivo and in vitro models of myocardial infarction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:48.393956+00:00"}
{"study_id": 48693, "supplement_id": 1525, "safety_score": "90", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Rosmarinic Acid (RA) exhibits cytotoxic effects against medulloblastoma (MB) cells and explore its potential mechanisms of action.", "results_summary": "RA demonstrated cytotoxicity against human MB cells (Daoy and D283), reduced HDAC1 and EGFR expression, inhibited ERK1/2 and AKT signaling, increased p21 expression, and decreased cancer stem cell markers and neurosphere size, suggesting reduced proliferation and stemness.", "population_specificity": "Human medulloblastoma cell lines (Daoy and D283).", "effective_dosage": "IC50 values of 168 \u03bcM (Daoy) and 334 \u03bcM (D283).", "study_duration": "48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:48.560373+00:00"}
{"study_id": 48690, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the synergistic protective effects of rosmarinic acid (RA) and madecassoside (MD) against UVB-induced photoaging in Hs68 cells.", "results_summary": "The MD-RA combination at a 3:7 ratio showed strong synergistic effects in protecting against UVB-induced damage, improving cell viability, antioxidant activity, and collagen production, outperforming either compound alone.", "population_specificity": "Hs68 cells (human fibroblast cell line)", "effective_dosage": "Various ratios (9:1 to 1:9, v/v), with the most effective being 3:7 (MD-RA)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:48.634756+00:00"}
{"study_id": 48694, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the therapeutic potential of rosmarinic acid nanoparticles (RNPs) for rheumatoid arthritis (RA) treatment by assessing their ability to scavenge reactive oxygen and nitrogen species (RONS) and repolarize macrophages from pro-inflammatory M1 to anti-inflammatory M2 phenotypes.", "results_summary": "The study found that RNPs effectively scavenged RONS and pro-inflammatory cytokines, targeted inflamed joints in collagen-induced arthritis (CIA) rats, alleviated RA symptoms (joint swelling, synovial hyperplasia, cartilage degradation, and bone erosion), and promoted macrophage polarization from M1 to M2 phenotype.", "population_specificity": "Collagen-induced arthritis (CIA) rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:49.195815+00:00"}
{"study_id": 48696, "supplement_id": 1525, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of oral Rosmarinic Acid (RA) in promoting healthspan, particularly cognitive function and metabolic health, in aged mice compared to young controls.", "results_summary": "RA improved learning, memory, and glucose homeostasis in aged mice but disrupted lipid profiles and worsened glycemic control in young males while reducing BDNF levels in young females, indicating sex-dependent effects.", "population_specificity": "Aged (24-month-old) and young (3-month-old) C57Bl/6 mice, both male and female.", "effective_dosage": "500 mg/kg administered in drinking bottles.", "study_duration": "52 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:54.063458+00:00"}
{"study_id": 48697, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate rosmarinic acid's modulatory effect on H2O2-induced oxidative stress and glycolytic adaptive responses in fibroblasts.", "results_summary": "Rosmarinic acid significantly reduced ROS levels, modulated glucose metabolism, downregulated glycolytic enzymes, and upregulated key antioxidant enzymes in H2O2-treated fibroblasts. It also restored intracellular ATP and decreased NADPH production via the pentose phosphate pathway.", "population_specificity": "Human dermal fibroblasts", "effective_dosage": "5-50 \u00b5M", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:54.730138+00:00"}
{"study_id": 48702, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory and immunoregulation properties of rosmarinic acid (RosA) in an asthmatic mouse model.", "results_summary": "RosA demonstrated significant anti-asthma effects, regulating 90% of lipid mediator species affected by the Hyssopus cuspidatus extract (SXCF) and showing similar impacts on key asthma-related LMs. Some constituents in SXCF may mitigate excessive effects of RosA on LMs.", "population_specificity": "OVA-induced asthma model mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:56.936451+00:00"}
{"study_id": 48698, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory effects of Rosmarinic Acid (RA) loaded into exosomes (RLE) on LPS-induced endometritis in mice, focusing on the TLR4-NLRP3 signaling pathway.", "results_summary": "RA loaded into exosomes (RLE) and combined with exosomes (R+E) at 10 mg/kg significantly reduced inflammation, inhibited MPO activity, and suppressed TLR4, NLRP3, inflammatory cytokines (IL-1\u03b2, IL-18, TNF-\u03b1), and pyroptosis factor GSDM-D.", "population_specificity": "Female mice with LPS-induced endometritis.", "effective_dosage": "5 and 10 mg/kg of RA or exosome.", "study_duration": "24 hours after inducing endometritis.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:57.479103+00:00"}
{"study_id": 48699, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether rosmarinic acid (RA) could inhibit intracellular nucleic acid-stimulated interferon (IFN) expression and attenuate IFN-stimulated genes (ISGs) in models of autoimmune diseases like Aicardi-Gouti\u00e8res syndrome (AGS).", "results_summary": "Rosmarinic acid was found to inhibit intracellular nucleic acid-induced IFN expression by binding to G3BP1 and cGAS, disrupting DNA-cGAS interaction. It effectively reduced ISG expression in AGS cell models, suggesting potential for treating autoimmune responses triggered by aberrant nucleic acid sensing.", "population_specificity": "Cell models for Aicardi-Gouti\u00e8res syndrome (AGS)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:57.500978+00:00"}
{"study_id": 48701, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the antimicrobial effects of rosmarinic acid and its derivatives, both alone and in combination with antibiotics, and explore their mechanisms of action.", "results_summary": "Rosmarinic acid and its derivatives demonstrated antimicrobial activity against bacteria, fungi, and viruses, with synergistic effects observed when combined with antibiotics. The study highlighted their potential as alternative antimicrobial agents.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:57.570024+00:00"}
{"study_id": 48705, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the combined effect of Rosmarinic Acid (RA) and IDO1 gene silencing on the tumor immune microenvironment in hepatocellular carcinoma (HCC).", "results_summary": "The combination of RA and IDO1-shRNA significantly increased CD4+ T cells, CD4+/CD8+ ratio, IFN-\u03b3, and IL-2 levels while reducing CD8+ apoptosis, splenic Tregs proportion, TNF-\u03b1, and IL-10 levels, demonstrating anti-tumor effects in HCC.", "population_specificity": "H22 tumor-bearing mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:58.138224+00:00"}
{"study_id": 48704, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of methyl jasmonate (MeJA) on rosmarinic acid (RA) content, total flavonoid and phenolic contents (TFC and TPC), and the expression of key genes involved in their biosynthesis in Salvia yangii and Salvia abrotanoides.", "results_summary": "MeJA significantly increased RA content (1.66- and 1.54-fold in S. yangii and S. abrotanoides, respectively), along with TPC and TFC, and upregulated the expression of PAL, 4CL, and RAS genes involved in the phenylpropanoid pathway.", "population_specificity": "Salvia yangii and Salvia abrotanoides plants.", "effective_dosage": "150 \u00b5M MeJA.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:13:58.694334+00:00"}
{"study_id": 48706, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the chemopreventive and chemotherapeutic effects of Rosmarinic Acid (RA) and its derivatives to explore their potential as complementary cancer treatments.", "results_summary": "The study found that RA exhibits significant biological effects, including antiviral, antibacterial, anti-inflammatory, anti-tumour, antioxidant, and antiangiogenic properties. However, most evidence is preclinical, lacking clinical trial validation.", "population_specificity": "Not specified (preclinical studies primarily).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:02.082964+00:00"}
{"study_id": 48707, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether rosmarinic acid (RA) could counteract palmitate-induced insulin resistance in muscle cells and explore its potential antidiabetic properties.", "results_summary": "RA treatment abolished palmitate-induced serine phosphorylation of IRS-1, restored insulin-stimulated Akt activation, GLUT4 translocation, and glucose uptake, and reduced mTOR and p70S6K activation while increasing AMPK phosphorylation.", "population_specificity": "L6 muscle cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:02.783676+00:00"}
{"study_id": 48710, "supplement_id": 1525, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore the effect of rosmarinic acid (RA) on human metastatic melanoma cells, focusing on viability, migration, oxidative stress, and apoptosis-related gene expression.", "results_summary": "RA reduced melanoma cell viability and migration, induced apoptosis, decreased ROS levels, and increased antioxidant defenses. It showed no cytotoxic effects on non-tumoral cells.", "population_specificity": "Human metastatic melanoma cells (SK-MEL-28) and peripheral blood mononuclear cells (PBMCs).", "effective_dosage": "Different concentrations (specific amounts not stated).", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:06.306804+00:00"}
{"study_id": 48711, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the beneficial effects of rosmarinic acid (RA) in pilocarpine-induced epileptiform activity models, both in vitro and in vivo.", "results_summary": "RA decreased stimulated lactate release in vitro and attenuated SE-induced neuromotor impairment and protein carbonyl levels in vivo, suggesting beneficial effects in epileptiform activity models.", "population_specificity": "Wistar rats (in vitro) and male C57BL/6 mice (in vivo).", "effective_dosage": "10 \u00b5g/mL (in vitro), 30 mg/kg (in vivo, administered orally).", "study_duration": "1, 24, and 48 hours post-SE (in vivo).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:06.585679+00:00"}
{"study_id": 48709, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how rosmarinic acid (RA) regulates mucus barrier function, reshapes gut microbiota, and alleviates inflammation in colitis mice.", "results_summary": "RA treatment promoted goblet cell proliferation, restored mucus secretion (especially Muc2), reshaped gut microbiota (increasing beneficial probiotics), and increased beneficial metabolites (bile acids, indole metabolites, and SCFAs). RA also inhibited inflammasome overexpression (particularly NLRP6), enhancing mucus secretion and gut health.", "population_specificity": "Colitis mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:06.789149+00:00"}
{"study_id": 48712, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the therapeutic effects of Rosmarinic Acid (RA) against ER stress and impaired mitophagy in UV-B-induced photodamage models.", "results_summary": "RA alleviated ER stress and mitophagic responses, preventing intracellular damage in human dermal fibroblasts (HDFs) and irradiated Balb/C mice skin. The study demonstrated RA's role in reversing UV-B-induced toxic responses.", "population_specificity": "Primary human dermal fibroblasts (HDFs) and Balb/C mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:06.927434+00:00"}
{"study_id": 48708, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-pruritic effects of Rosmarinic Acid (RA) and explore its underlying mechanism in an allergic contact dermatitis (ACD) mouse model.", "results_summary": "RA treatment significantly reduced epidermal keratinization, inflammatory cell infiltration, histamine secretion, IL-13 levels, and CST-14 mRNA expression while increasing MRGPRX2 mRNA expression. RA also demonstrated affinity for MRGPRX2 and inhibited mast cell activation via the MRGPRX2-PLC\u03b31-PKC-NF-\u03baB pathway.", "population_specificity": "SPF Balb/c mice with induced allergic contact dermatitis.", "effective_dosage": "1.0 mg/kg", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:06.935702+00:00"}
{"study_id": 48713, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-atrophic effects of Rosmarinic Acid (RosA) on dexamethasone-induced skeletal muscle atrophy in C2C12 myotubes.", "results_summary": "RosA increased cell viability, inhibited protein degradation, promoted the Akt/p70S6K/mTOR pathway, reduced ROS production and apoptosis, and improved SOD activity, autophagy, mitochondrial contents, and ATP levels in DEX-treated myotubes.", "population_specificity": "C2C12 myotubes (in vitro model of skeletal muscle cells)", "effective_dosage": "Different concentrations (specific amounts not stated)", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:07.701486+00:00"}
{"study_id": 48714, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the self-regulated photodynamic and antimetastasis properties of a nanoassembly (CPR) containing rosmarinic acid (RA) in enhancing photodynamic therapy (PDT) efficacy and reducing tumor metastasis.", "results_summary": "CPR demonstrated enhanced tumor accumulation, generated ROS under laser irradiation to damage tumor cells, and scavenged excess ROS in the tumor microenvironment (TME) via RA and ferrocene. RA also reduced ferroptosis-generated Fc+ into Fc, augmenting PDT efficacy and hindering epithelial-mesenchymal transition to prevent lung metastasis.", "population_specificity": "Tumor cells and tumor microenvironment (in vitro/in vivo study, no human subjects specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:11.376297+00:00"}
{"study_id": 48715, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the anti-obesity effects of rosmarinic acid-rich 80EETC through gut microbiota modulation in high-fat diet-induced obese mice.", "results_summary": "80EETC administration significantly reduced body weight, fat accumulation, serum lipid levels, inflammation, and oxidative stress while improving gut microbiota composition in obese mice. The effects were dose-dependent, with higher doses showing greater efficacy.", "population_specificity": "High-fat diet-induced obese C57BL/6 mice.", "effective_dosage": "125 mg/kg (low dose) and 250 mg/kg (high dose) body weight.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:11.657946+00:00"}
{"study_id": 48721, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review preclinical and clinical studies examining the effects of rosmarinic acid and other compounds on allergic and immunologic disorders.", "results_summary": "Rosmarinic acid showed promise in treating asthma by suppressing the NF-\u03baB pathway, while other compounds reduced inflammatory cytokines and improved airway inflammation. The compounds also demonstrated anti-cancer effects and antispasmodic properties.", "population_specificity": "Preclinical and clinical studies (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:14.851437+00:00"}
{"study_id": 48716, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the anti-inflammatory effects of luteolin-coated RA-SS-mPEG polymer micelles (L-RSPMs) containing rosmarinic acid on a TNBS-induced ulcerative colitis model in rats.", "results_summary": "L-RSPMs improved bioavailability, reduced inflammatory markers (MDA, PEG2, CRP, TNF-\u03b1, IL-6, IL-1\u03b2), increased anti-inflammatory cytokines (IL-10, SOD), and alleviated colon inflammation in colitic rats.", "population_specificity": "TNBS-induced ulcerative colitis model in rats.", "effective_dosage": "Low and high doses (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:15.287524+00:00"}
{"study_id": 93895, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the pharmacological properties and clinical applications of salvianolic acids (including Rosmarinic Acid) for treating ischemic stroke and other cerebrovascular diseases.", "results_summary": "The study found that salvianolic acids, including Rosmarinic Acid, exhibit multiple beneficial effects such as reducing neuroinflammation, alleviating oxidative stress, inhibiting apoptosis, preserving endothelial function, and promoting angiogenesis, making them effective for cerebrovascular conditions.", "population_specificity": "Patients with cardiovascular and cerebrovascular diseases, including ischemic stroke.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:16.104347+00:00"}
{"study_id": 48720, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify and evaluate the active component in Salvia miltiorrhizae that acts on TRPC1, focusing on Rosmarinic Acid's potential for myocardial injury therapy.", "results_summary": "Rosmarinic Acid (RosA) showed high binding affinity to TRPC1 protein (KD = 1.27 \u00b5M), reduced TRPC1 protein levels by 417.1% in HL-1 cells after OGD/R, and inhibited TRPC1-mediated Ca2+ influx injury in HEK293 cells.", "population_specificity": "In vitro studies using HL-1 and HEK293 cell lines.", "effective_dosage": "50 \u00b5M", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:16.477916+00:00"}
{"study_id": 48719, "supplement_id": 1525, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Rosmarinic Acid (RA) could reduce the hepatotoxicity of Tacrine (TAC) and synergistically enhance its therapeutic effects on Alzheimer's disease in mice.", "results_summary": "RA combined with TAC improved cognitive behavior and brain pathology in AD mice, reduced A\u03b2 oligomer expression, inhibited A\u03b2 deposition, and lowered AChE activity while increasing Ach levels. RA also alleviated TAC-induced hepatotoxicity by inhibiting apoptosis pathways and reducing liver injury.", "population_specificity": "6-month-old APP/PS1 double-transgenic mice and wild-type mice.", "effective_dosage": "Low dose (RA-L) and high dose (RA-H) of Rosmarinic Acid (specific amounts not provided).", "study_duration": "Not specified in the abstract.", "interactions": "Tacrine (TAC) and Silymarin (SIL).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:16.571605+00:00"}
{"study_id": 48717, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Origanum dictamnus L. as an in vitro adventitious root culture system for producing rosmarinic acid (RA) and assess its biomass production and yield under different culture conditions.", "results_summary": "The study found that RA was produced in vitro across all treatments, with the ODY1 medium and 200-day culture period being most effective for RA and biomass production. The highest RA content (6.6% dry weight) and yield indices were observed in roots derived from petiole calluses after 240 days.", "population_specificity": "In vitro plant cultures (Origanum dictamnus L.)", "effective_dosage": "Not specified (culture media supplemented with 35 \u03bcM IBA + 2.5 \u03bcM kinetin or 5 \u03bcM NAA + 0.5 \u03bcM kinetin)", "study_duration": "Up to 240 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:16.918551+00:00"}
{"study_id": 93903, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the mechanisms and potential benefits of Rosmarinic Acid as an anti-aging agent, focusing on its anti-glycation properties.", "results_summary": "The study highlighted Rosmarinic Acid's role in mitigating age-related protein crosslinks, which are linked to age-related diseases, but did not provide specific clinical outcomes or statistical evidence.", "population_specificity": "Not specified (general review of anti-aging strategies)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:19.343796+00:00"}
{"study_id": 93899, "supplement_id": 1525, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the potential of Rosmarinic Acid, among other TCM products, to impede colorectal cancer (CRC) development through modulation of the TLR4 signaling pathway.", "results_summary": "The abstract suggests that Rosmarinic Acid may have potential to inhibit CRC progression by targeting the TLR4 signaling pathway, though specific results or mechanisms are not detailed.", "population_specificity": "The study broadly references CRC patients and the role of TLR4 signaling, but no specific population was studied for Rosmarinic Acid.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:20.042853+00:00"}
{"study_id": 96623, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of T lymphocytes in salt-sensitive hypertension and vascular remodeling, exploring potential therapeutic targets.", "results_summary": "The study found that specific subsets of T lymphocytes play critical roles in salt-sensitive hypertension and vascular remodeling, with inflammatory responses potentially triggered by oxidative stress in the brain. These findings suggest new therapeutic targets for cardiovascular and renal diseases.", "population_specificity": "Not specified (likely animal models or general hypertensive populations based on context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:29.139438+00:00"}
{"study_id": 96626, "supplement_id": 1536, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and antitumor efficacy of palifosfamide-tris, a salt-stabilized formulation of isophosphoramide mustard, compared to ifosfamide.", "results_summary": "Preclinical and clinical trials showed palifosfamide-tris had comparable or superior antitumor efficacy to ifosfamide without causing neurotoxic or nephrotoxic side effects. Phase II data were under evaluation, and phase III trials were planned.", "population_specificity": "Patients with bone and soft-tissue sarcoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:29.464990+00:00"}
{"study_id": 96625, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the impact of fluid management strategies, including salt and water overload, on patients with or at risk of acute kidney injury (AKI).", "results_summary": "The study found that overzealous fluid therapy, including salt and water overload, can lead to organ dysfunction, impaired wound healing, and nosocomial infections in AKI patients. Conservative fluid strategies were advocated to improve outcomes, though careful balance is needed to avoid hypovolemia.", "population_specificity": "Patients with or at risk of acute kidney injury (AKI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:30.362723+00:00"}
{"study_id": 96627, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the transdermal delivery efficiency, solubility, and iontophoretic performance of rotigotine.H(3)PO(4) versus rotigotine.HCl.", "results_summary": "Rotigotine.H(3)PO(4) showed significantly higher solubility and a 170% increase in maximum flux compared to rotigotine.HCl, with optimal delivery efficiency achieved at donor pH 5-6. Therapeutic levels were achievable via iontophoresis with rapid onset and controlled maintenance.", "population_specificity": "Not specified (in vitro and in silico study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:30.456301+00:00"}
{"study_id": 96628, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of electrostatic arginine-phosphate salt bridges in GPCR heteromers and their potential relevance in treating Parkinson's disease and schizophrenia.", "results_summary": "The study found that the arginine-phosphate salt bridge in adenosine A(2A)-dopamine D(2)-like heteromers may be a key interface with covalent-like stability, potentially enabling allosteric interactions and integration of heteromer receptor function. The relevance of D(2) receptor heteromers in treating Parkinson's disease and schizophrenia was discussed.", "population_specificity": "Not specified (focus on cellular and molecular mechanisms in living cells).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:30.816411+00:00"}
{"study_id": 96622, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of a low-salt diet on urinary calcium excretion in patients with idiopathic calcium nephrolithiasis and hypercalciuria.", "results_summary": "The low-salt diet significantly reduced urinary sodium, calcium, and oxalate excretion compared to the control diet, with 61.9% of patients on the low-salt diet achieving normal urinary calcium levels versus 34.0% on the control diet.", "population_specificity": "Patients with idiopathic calcium stone disease and hypercalciuria (>300 mg Ca/d in men and >250 mg Ca/d in women).", "effective_dosage": "Not specified (low-sodium diet intervention).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:33.899725+00:00"}
{"study_id": 96624, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate five different laboratory methods for identifying methicillin-resistant Staphylococcus aureus (MRSA) compared to PCR as the gold standard.", "results_summary": "The study found that MSC-6 (mannitol salt cefoxitin agar with 6 microg/ml cefoxitin) and ORSAB (oxacillin resistance screening agar base) were the most accurate and cost-effective methods for MRSA screening, with MSC-6 showing high sensitivity (98.9%) and specificity (94.9%). All tested methods were comparable, but MSC-6 was the least expensive.", "population_specificity": "207 S. aureus clinical isolates (89 MRSA and 118 MSSA strains).", "effective_dosage": "Not applicable (laboratory methods, not human dosage).", "study_duration": "Not applicable (laboratory study, no intervention duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:34.310086+00:00"}
{"study_id": 96629, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the antitumor activity of vorinostat, alone and in combination with melphalan or bortezomib, against multiple myeloma in cell lines and a murine xenograft model.", "results_summary": "Vorinostat enhanced the anti-myeloma effects of melphalan and bortezomib both in vitro and in vivo, showing significant tumor growth inhibition in combination therapies compared to single-agent treatments. Synergistic effects were observed in specific cell lines and in vivo models.", "population_specificity": "Multiple myeloma cell lines (RPMI8226, U266, MM1S) and severe combined immunodeficient mice bearing LAGkappa-1B tumors.", "effective_dosage": "Vorinostat (30, 60, 100 mg/kg daily for five days per week; 100, 300 mg/kg twice weekly), melphalan (1, 3, 10 mg/kg once weekly), bortezomib (0.25, 0.5 mg/kg twice weekly).", "study_duration": "35 days.", "interactions": "Enhanced effects when combined with melphalan or bortezomib.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:36.705334+00:00"}
{"study_id": 96633, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of altered epithelial salt transport in cystic fibrosis (CF) lung disease and the development of novel therapies targeting the underlying CFTR defect.", "results_summary": "The abstract describes that CFTR dysfunction leads to impaired salt and water transport in the lungs, resulting in mucociliary clearance issues, chronic infection, inflammation, and tissue damage. It mentions recent advances in therapies targeting the CFTR defect but does not provide specific results regarding salt's effects.", "population_specificity": "Individuals with cystic fibrosis (CF).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:39.512512+00:00"}
{"study_id": 96632, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the therapeutic effects of ACE inhibitors, including their impact on salt balance and cardiovascular/renal diseases.", "results_summary": "ACE inhibitors restore the balance between angiotensin II and bradykinin, reduce systemic vascular resistance, promote natriuresis, and are effective in treating hypertension, heart failure, and diabetic complications. They also show potential in memory-related disorders and cancer.", "population_specificity": "Patients with cardiovascular and renal diseases, including hypertension, congestive heart failure, and diabetic nephropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:39.548623+00:00"}
{"study_id": 96630, "supplement_id": 1536, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the in vitro, in vivo, toxicological, and clinical efficacy and safety of Rifacinna (a sodium salt derivative) compared to other rifamycin antibiotics for treating bacterial and mycobacterial infections, including tuberculosis.", "results_summary": "Rifacinna demonstrated excellent in vitro and in vivo activity against a broad spectrum of pathogens, including drug-resistant strains, with high intraphagocytic efficacy and complete eradication of mycobacteria in tuberculosis models. Clinical studies showed superior therapeutic efficacy and safety compared to rifampicin in pulmonary tuberculosis patients.", "population_specificity": "Patients with infiltrative, disseminated, and cavitary forms of pulmonary tuberculosis, as well as in vitro and in vivo models of bacterial and mycobacterial infections.", "effective_dosage": "10 mg/kg single daily dose (in vivo).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:39.806049+00:00"}
{"study_id": 96631, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To summarize data on congenital chloride diarrhoea diagnosis, pathophysiology, and treatment, and to provide guidelines for acute and long-term management.", "results_summary": "Life-long salt substitution with NaCl and KCl stabilizes fluid, electrolyte, and acid-base balance in congenital chloride diarrhoea patients, leading to favourable long-term outcomes when properly treated. Acute management includes addressing dehydration, hypokalaemia, and other disease manifestations like renal impairment and male subfertility.", "population_specificity": "Patients with congenital chloride diarrhoea, primarily newborns and adults.", "effective_dosage": "Not specified", "study_duration": "Life-long", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:40.271380+00:00"}
{"study_id": 96634, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the performance of Spectra MRSA medium with traditional media (SBA and MSA) for detecting methicillin-resistant Staphylococcus aureus (MRSA) in nasal swab specimens.", "results_summary": "Spectra MRSA demonstrated high sensitivity (95.4% in multicenter study, 95.2% at MCW) and specificity (99.7% in multicenter study, 99.5% at MCW) at 24 hours, outperforming traditional media in most comparisons. Extending incubation beyond 24 hours did not improve MRSA recovery and reduced specificity.", "population_specificity": "Nasal swab specimens from multicenter study (767 samples) and MCW (667 samples).", "effective_dosage": "Not applicable (diagnostic medium comparison).", "study_duration": "24-48 hours of incubation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:41.274713+00:00"}
{"study_id": 96635, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of intensive insulin therapy alone or with added pioglitazone on renal salt/water balance and body fluid compartment shifts in type 2 diabetes.", "results_summary": "The study found that pioglitazone, when added to intensive insulin therapy, caused greater weight gain and a shift in body water distribution to extracellular and interstitial compartments compared to insulin alone. Pioglitazone also increased the filtered load of sodium reabsorbed at the distal nephron without a net change in fractional excretion of sodium.", "population_specificity": "25 insulin-treated, obese patients with type 2 diabetes.", "effective_dosage": "Pioglitazone 45 mg daily.", "study_duration": "12-16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:43.184718+00:00"}
{"study_id": 96636, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of subconjunctival bevacizumab compared to balanced salt solution as an adjunctive therapy for primary pterygium surgery.", "results_summary": "The study found no statistically significant differences in recurrence rates, corneal epithelial defect healing, or postoperative symptoms between the bevacizumab and balanced salt solution groups. Both groups showed similar resolution rates (86.6%) and recurrence rates (13.4%).", "population_specificity": "30 eyes of 30 patients undergoing primary pterygium surgery.", "effective_dosage": "0.1 ml balanced salt solution administered subconjunctivally.", "study_duration": "Single intraoperative administration with follow-up periods of 7.4-8 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:43.893468+00:00"}
{"study_id": 96637, "supplement_id": 1536, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of sodium chenodeoxycholate (CDC) on colonic transit in healthy volunteers and the effects of colesevelam on transit and bowel function in diarrhea-predominant irritable bowel syndrome (IBS-D) patients.", "results_summary": "CDC significantly accelerated colonic transit, increased stool frequency, and improved ease of passage in healthy volunteers. Colesevelam modestly affected colonic transit in IBS-D patients, with slower ascending colon emptying and improved stool passage ease, but no significant impact on mucosal permeability or safety.", "population_specificity": "Healthy volunteers (20 per group) and IBS-D patients (24 total, 12 per group).", "effective_dosage": "CDC (500 mg or 1000 mg delayed-release); colesevelam (1.875 g twice daily).", "study_duration": "4 days for CDC; duration for colesevelam not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:47.793142+00:00"}
{"study_id": 96641, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the occurrence, characterization, importance, applications, and genetics of bile salt hydrolase (BSH) in probiotics and its potential to reduce blood cholesterol levels.", "results_summary": "The abstract highlights that probiotics with BSH are more tolerant to bile salts and may help reduce host blood cholesterol levels, but research in this area is still in its infancy with significant gaps remaining.", "population_specificity": "Not specified (general review, no specific population studied).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:48.075100+00:00"}
{"study_id": 96638, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical evidence on the use of topical sucralfate for managing epithelial wounds and explore its molecular mechanisms in wound healing.", "results_summary": "The study found that sucralfate is effective in healing various epithelial wounds, including ulcers, dermatitis, mucositis, and burns, by promoting granulation tissue development and wound space filling. It highlights sucralfate's role in the wound healing process involving hemostasis, inflammation, cell proliferation, and tissue remodeling.", "population_specificity": "Patients with epithelial wounds such as ulcers, inflammatory dermatitis, mucositis, and burn wounds.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:48.498491+00:00"}
{"study_id": 96639, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the state of knowledge about glucosamine (GlcN) salts in relation to osteoarthritis (OA), including their chemistry, biological effects, therapeutic potential, and clinical applications.", "results_summary": "The study discusses potent pleiotropic activities of GlcN in vitro and in animal models but notes ongoing controversy about its effectiveness vs. placebo in clinical trials. Future research is needed to standardize testing methods and develop new outcome measures for human OA.", "population_specificity": "Humans and animal models with osteoarthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:48.639626+00:00"}
{"study_id": 96640, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of vasopressin and oxytocin in salt and water imbalance in patients with chronic heart failure.", "results_summary": "The study found a significant increase in vasopressin-positive neurons and vasopressin-immunoreactivity in the posterior pituitary of chronic heart failure patients, but no significant changes in oxytocin neurons compared to controls.", "population_specificity": "Male patients who died from chronic heart failure (8 patients, 53.8\u00b19.3 years) and male controls (9 controls, 54.6\u00b111.8 years).", "effective_dosage": "Not available", "study_duration": "Not applicable (postmortem analysis)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:49.463576+00:00"}
{"study_id": 96643, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of nucleocytoplasmic lectins in plant stress physiology, including high salt conditions.", "results_summary": "The study found that plants synthesize small amounts of carbohydrate-binding proteins (lectins) in response to stress, including high salt, and these lectins may play a key role in stress physiology within the cytoplasm and nucleus.", "population_specificity": "Plants (not human or animal subjects)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:51.054125+00:00"}
{"study_id": 96644, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of dendrimers as gene delivery vectors, focusing on factors like salt concentration affecting nucleic acid-dendrimer complex formation.", "results_summary": "The abstract discusses how salt concentration influences dendrimer-nucleic acid interactions but does not report specific results on salt's effects.", "population_specificity": "Not specified (in vitro and in vivo studies referenced).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:52.939976+00:00"}
{"study_id": 201559, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review mechanisms and environmental factors contributing to racial disparities in salt-sensitive blood pressure.", "results_summary": "The study found racial differences in diet and hydration influencing salt sensitivity, with dietary salt negatively affecting gut microbiota and immune function, increasing hypertension risk. Antioxidant supplementation and exercise were noted to offset vascular dysfunction from salt intake, including in Black adults.", "population_specificity": "Racial groups, particularly Black adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:55.877961+00:00"}
{"study_id": 96645, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of venous congestion and elevated intra-abdominal pressure in renal impairment during heart failure treatment, and the potential for renal-sparing approaches involving salt and water removal.", "results_summary": "The study highlights emerging data suggesting venous congestion and elevated intra-abdominal pressure, rather than just impaired cardiac output, as primary drivers of renal impairment in heart failure. It proposes the need for better methods to distinguish haemodynamic versus nephrotoxic causes and supports novel renal-sparing approaches for salt and water removal.", "population_specificity": "Patients with acute decompensated heart failure (ADHF) experiencing worsening renal function.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:57.328149+00:00"}
{"study_id": 201562, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to systematically review and meta-analyze the effects of exogenous ketones (including salts) on blood glucose levels.", "results_summary": "The study found that exogenous ketones, including salts, significantly increased blood BHB and decreased blood glucose levels, with greater effects observed for ketone monoesters compared to salts.", "population_specificity": "586 participants across 43 trials (specific population details not provided in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Acute ingestion (specific duration not detailed).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:57.655970+00:00"}
{"study_id": 201561, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the relationship between bile acids, gut microbial bile salt hydrolases (BSHs), and farnesoid X receptor (FXR) signaling, and summarize dietary regulators of BSH and FXR activities.", "results_summary": "The study generalized the role of BSHs in linking dietary supplements to gut microbiota and BAs-FXR signaling, highlighting the compound-specific effects of bile acids on FXR activity and host metabolism. It did not directly assess Salt's effects.", "population_specificity": "Not specified (general review of gut microbiota and dietary supplements)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:57.735961+00:00"}
{"study_id": 201560, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of ketone ester (KE) ingestion on exercise cardiac output and the influence of blood acidosis, with salt placebo used as a control.", "results_summary": "KE ingestion did not increase cardiac output during submaximal exercise despite elevating heart rate, and this effect was independent of blood acidosis. Peak workload was lower with KE ingestion compared to the salt placebo.", "population_specificity": "15 endurance-trained adults with a peak oxygen uptake of 60 \u00b1 9 mL\u00b7kg\u207b\u00b9\u00b7min\u207b\u00b9.", "effective_dosage": "0.2 g\u00b7kg\u207b\u00b9 sodium bicarbonate or salt placebo 60 min before exercise.", "study_duration": "Single session with measurements taken during and after 30 min of cycling.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:14:58.312098+00:00"}
{"study_id": 201563, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of consuming ketone supplements (including ketone salts) on enhancing physical performance by aggregating data from randomized controlled trials.", "results_summary": "The systematic review found mixed results, with 3 studies reporting positive effects, 10 reporting null effects, and 3 reporting negative effects of ketone supplementation on physical performance. High heterogeneity across studies made it difficult to draw definitive conclusions about the benefits or detriments of ketone supplements.", "population_specificity": "112 participants (109 men, 3 women) across 10 studies.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:00.063568+00:00"}
{"study_id": 201564, "supplement_id": 1536, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of dietary salt supplementation on 24-hour mean arterial blood pressure variability (24hBPV) in patients with type 2 diabetes mellitus (T2DM) during angiotensin II receptor blocker (telmisartan) use.", "results_summary": "The study found that salt supplementation did not significantly increase 24hBPV, suggesting no short-term deleterious effects. Predicted 24hBPV was higher with telmisartan alone compared to baseline, but salt supplementation did not further elevate it.", "population_specificity": "Patients with type 2 diabetes mellitus (n=28).", "effective_dosage": "100 mmol/24 h (sodium chloride capsules).", "study_duration": "2 weeks per intervention phase, with a 6-week washout between phases.", "interactions": "Interaction noted with telmisartan (angiotensin II receptor blocker).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:03.958288+00:00"}
{"study_id": 96642, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to assess sensory preferences and discrimination ability for salt (among other tastes) in obese children and adolescents before and after a lifestyle intervention.", "results_summary": "The study found no significant differences in preference or sensitivity to salt across the three testing time points (baseline, 3 months, and 12 months).", "population_specificity": "Obese children and adolescents aged 7-16 years (N=72).", "effective_dosage": "Not specified (table salt was added to customary foods, but exact amounts are not provided).", "study_duration": "12 months (with assessments at baseline, 3 months, and 12 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:04.349798+00:00"}
{"study_id": 201568, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the strengths and areas for improvement in population-based and targeted fortification programs, including those involving salt.", "results_summary": "The study identified successful fortification programs with high coverage and equitable distribution, as well as programs with potential but low compliance. Some programs had limited public health impact due to low consumption of the fortified food vehicle.", "population_specificity": "General population, including vulnerable groups (e.g., infants and young children).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:05.321939+00:00"}
{"study_id": 201566, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of microbiota metabolites in influencing non-traditional risk factors like inflammation and endothelial dysfunction in CKD-associated cardiovascular damage, including potential links to blood pressure regulation and hypertension.", "results_summary": "The abstract suggests that microbiota metabolites may influence CKD-associated cardiovascular damage and highlights the need to integrate traditional salt and protein restriction with foods that enhance intestinal wellness, but does not provide specific results on salt's effects.", "population_specificity": "Patients with chronic kidney disease (CKD) and associated cardiovascular damage.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:05.600813+00:00"}
{"study_id": 201569, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of oral ATP supplementation (as disodium salt) on postexercise ATP levels, muscle activation, excitability, and power following repeated sprint bouts.", "results_summary": "Oral ATP supplementation prevented postexercise declines in ATP, ADP, and AMP levels, maintained muscle excitability in later sprint bouts, and significantly increased Wingate peak power compared to baseline.", "population_specificity": "42 healthy male individuals", "effective_dosage": "400 mg of ATP as disodium salt", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:06.321210+00:00"}
{"study_id": 201565, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of acutely raising blood \u03b2-hydroxybutyrate (\u03b2-OHB) using ketone salts or monoesters on NLRP3 inflammasome activation in healthy humans.", "results_summary": "The study found that both ketone salt and monoester supplementation increased markers of NLRP3 inflammasome activation (caspase-1 and IL-1\u03b2 secretion), suggesting that raising \u03b2-OHB exogenously may augment inflammatory activation. IL1B and NLRP3 mRNA levels remained unchanged.", "population_specificity": "Healthy males (Study 1, N=10) and equal males/females (Study 2, N=18).", "effective_dosage": "Ketone salts (0.3 g \u03b2-OHB per kg) or ketone monoester (0.482 g \u03b2-OHB per kg).", "study_duration": "Single administration with measurements at baseline and 30 minutes post-supplementation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:06.666921+00:00"}
{"study_id": 201567, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of oral sodium chloride supplementation on growth, hydrocortisone and fludrocortisone dose, and adrenal crisis frequency in infants with salt-wasting CAH.", "results_summary": "Approximately 27.7% of infants received sodium chloride supplementation, with no significant differences in growth, medication doses, or adrenal crisis frequency between supplemented and unsupplemented groups. Supplementation rates increased over time but showed no measurable benefits.", "population_specificity": "311 infants with salt-wasting congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (133 females, 178 males).", "effective_dosage": "0.9 \u00b1 1.4 mmol/kg/day (excluding nutritional sodium content).", "study_duration": "First year of life.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:07.468642+00:00"}
{"study_id": 201570, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the optimal dose, frequency, and choice of zinc salt for supplementation to address zinc deficiency and related conditions.", "results_summary": "The study discusses the use of zinc stable isotope tracer techniques to better understand zinc metabolism and supplementation pharmacokinetics, suggesting that long-term preventive zinc supplementation may require less frequent dosing than daily.", "population_specificity": "Young children in low-income countries with diarrhoea and environmental enteropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:07.970952+00:00"}
{"study_id": 201571, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine if oral salt supplementation improves sweat collection rates in young infants undergoing sweat testing for cystic fibrosis.", "results_summary": "The study found that salt supplementation (750 mg) did not significantly reduce inadequate sweat collection rates (11.8% in the salt group vs. 5.2% in controls, p = 0.16).", "population_specificity": "Young infants (\u2264 3 months) referred for cystic fibrosis sweat testing.", "effective_dosage": "1/8th teaspoon salt (750 mg) mixed in formula feeds 1 day prior to testing.", "study_duration": "1 day", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:12.686552+00:00"}
{"study_id": 201572, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of telmisartan with and without dietary sodium chloride supplementation on blood pressure, plasma renin activity, serum aldosterone, and kidney function in hypertensive patients with type 2 diabetes.", "results_summary": "Salt supplementation blunted the telmisartan-induced increase in plasma renin activity by approximately 50% and reduced its blood pressure-lowering effects. A trend toward blunting of ARB-induced increases in serum aldosterone was also observed.", "population_specificity": "Hypertensive patients with type 2 diabetes (n=28).", "effective_dosage": "100 mmol/24 h (as NaCl capsules).", "study_duration": "2 weeks per phase (with a 6-week washout between phases).", "interactions": "Telmisartan (ARB medication).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:13.640787+00:00"}
{"study_id": 201574, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to systematically review and analyze electrolyte imbalances, including salt-related abnormalities, in patients with cystic fibrosis.", "results_summary": "The study found that electrolyte imbalances (hyponatremia, hypokalemia, hypochloremia) were common in cystic fibrosis patients, often linked to fluid volume depletion, and frequently occurred before diagnosis. Subacute cases showed more pronounced hyponatremia, while chronic cases were managed with oral salt supplementation.", "population_specificity": "Patients with cystic fibrosis, predominantly aged \u22642.5 years.", "effective_dosage": "Not specified (oral salt supplementation mentioned for chronic cases, but no dosage details provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:14.825692+00:00"}
{"study_id": 201575, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of zinc supplementation in preventing diarrhea-related outcomes, including incidence, prevalence, persistent diarrhea, dysentery, and mortality.", "results_summary": "Zinc supplementation showed modest benefits in reducing diarrhea incidence (9% reduction) and stronger benefits in reducing prevalence (19% reduction) and multiple diarrheal episodes (28% reduction), but no significant effects on persistent diarrhea, dysentery, or mortality. The evidence was inconclusive due to significant heterogeneity.", "population_specificity": "Children (specific age range not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:15.116748+00:00"}
{"study_id": 201576, "supplement_id": 1536, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether 28 days of L-arginine supplementation affects VO2max and ventilatory threshold (VT) in trained male cyclists.", "results_summary": "The study found that L-arginine supplementation had no significant effect on VO2max or VT in trained male cyclists, with no differences observed between the supplemented and placebo groups.", "population_specificity": "Endurance-trained male cyclists (mean age 36.3 \u00b1 7.9 years).", "effective_dosage": "2 \u00d7 6 g\u00b7d (12 g per day).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:15.167460+00:00"}
{"study_id": 36596, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the efficacy and safety of sarcosine as an add-on therapy to SSRIs in patients with major depressive disorder (MDD).", "results_summary": "The study found that sarcosine significantly improved depressive symptoms (greater reduction in MADRS scores), response rates, and remission rates compared to placebo. It also increased serum BDNF and glycine levels more than the control group.", "population_specificity": "60 participants with major depressive disorder (MDD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:15.786566+00:00"}
{"study_id": 36598, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop an efficient, low-skill, on-site detection method for sarcosine (Sar) as a biomarker for early prostatic cancer (PCa) using a dual-mode multi-enzyme cascade nanoplatform.", "results_summary": "The study successfully synthesized organic-inorganic self-assembled nanoflowers (Cu3(PO4)2:Ce@SOX) with enhanced catalytic activity, enabling dual-mode (fluorescence and colorimetric) Sar detection with high sensitivity and low detection limits. The platform also demonstrated exceptional repeatability, stability, and suitability for real-time Sar analysis in human urine samples.", "population_specificity": "Human urine samples (specific patient demographics not detailed).", "effective_dosage": "Not specified (detection ranges: 0.5\u201360 \u03bcM for fluorescence, 0.18\u201360 \u03bcM for colorimetric).", "study_duration": "Not specified (focused on method development rather than intervention duration).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:19.317325+00:00"}
{"study_id": 36599, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether sarcosine improves negative symptoms of schizophrenia and if these effects are mediated by changes in serum EGF levels.", "results_summary": "Sarcosine significantly improved negative symptoms, general psychopathology, and overall PANSS scores but did not affect serum EGF levels. The placebo group showed a reduction in EGF levels, while sarcosine maintained stable EGF levels, suggesting a neuroprotective effect.", "population_specificity": "58 subjects with chronic schizophrenia and dominant negative symptoms, stably treated with antipsychotics.", "effective_dosage": "2 g daily, orally", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:21.371694+00:00"}
{"study_id": 36605, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the neuroprotective potential of sarcosine in in vitro and in vivo Alzheimer's disease models.", "results_summary": "Sarcosine increased cell viability against aluminum-induced neurotoxicity in vitro and improved AD-associated pathologies in AlCl3-induced rats, including enhanced antioxidant capacity and reduced expression of AD-related genes.", "population_specificity": "AlCl3-induced rat model of Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:23.236147+00:00"}
{"study_id": 36604, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the therapeutic mechanisms and efficacy of sarcosine, benzoate, and ketamine derivatives in treating depression by modulating NMDARs and reducing inflammation.", "results_summary": "Sarcosine demonstrated efficacy in animal models and human trials by modulating NMDARs and inhibiting microglial activity, suggesting anti-inflammatory and antidepressant effects. It was comparable to other compounds like ketamine and benzoate in its therapeutic potential.", "population_specificity": "Animal models and human trials (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:23.344290+00:00"}
{"study_id": 36600, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of sarcosine in promoting malignant phenotypes in bladder cancer, particularly its association with GNMT expression and urinary sarcosine levels as a potential marker for muscle invasion.", "results_summary": "Sarcosine production, driven by GNMT expression, promoted cancer proliferation, invasion, and drug resistance in invasive bladder cancer cells (T24), while non-invasive cells (RT4) showed no such effects. Urinary sarcosine levels correlated with tumor weight and muscle invasion in human bladder cancer cases.", "population_specificity": "T24 (invasive bladder cancer) and RT4 (non-invasive bladder cancer) cell lines, nude mice, and 86 human bladder cancer cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:24.233203+00:00"}
{"study_id": 36603, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sarcosine could attenuate ketamine-induced schizophrenia-like symptoms in a rat model by modulating oxidative stress, mitochondrial dysfunction, and neuroinflammation.", "results_summary": "Sarcosine reversed ketamine-induced behavioral impairments, reduced oxidative and nitrosative stress, improved mitochondrial function, and decreased neuroinflammation, showing protective effects in histopathological analysis.", "population_specificity": "Rat model of schizophrenia induced by ketamine.", "effective_dosage": "300 and 600 mg/kg, intraperitoneal injection.", "study_duration": "7 days of sarcosine treatment following 10 days of ketamine induction.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:24.788865+00:00"}
{"study_id": 36601, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop portable, disposable, and sensitive sarcosine solid-contact ion-selective potentiometric sensors for rapid determination of sarcosine as a prostate cancer biomarker in urine.", "results_summary": "The study found that PANI-WO3 nanocomposite-based sensors offered the best performance, with the lowest potential drift (0.5 mV h-1), longest lifetime (4 months), and best limit of detection (9.95 \u00d7 10-13 M). The sensors successfully detected sarcosine in urine without prior sample treatment, meeting WHO ASSURED criteria for point-of-care diagnostics.", "population_specificity": "Not specified (urine samples analyzed, but human population details not provided).", "effective_dosage": "Not applicable (sensor performance study, not dosage-based).", "study_duration": "Not applicable (sensor lifetime tested over 4 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:25.161623+00:00"}
{"study_id": 36606, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop and validate a novel method for extracting and quantifying sarcosine in urine samples to evaluate its potential as a biomarker for prostate cancer.", "results_summary": "The study successfully fabricated a Hydro-MeC-MMIP for sarcosine extraction, achieving a linear range of 50-2000 ng mL-1, 96% recovery, and a detection limit of 9.93 ng mL-1. The method proved efficient, low-cost, and capable of resolving sarcosine from structural analogs like alanine and glycine.", "population_specificity": "Urine samples (specific human population not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:28.317961+00:00"}
{"study_id": 36607, "supplement_id": 1537, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the short- and long-term effectiveness of sarcosine as an add-on treatment for schizophrenia, focusing on symptom severity improvement via NMDA-receptor modulation.", "results_summary": "Sarcosine did not show significant overall effectiveness at pre-established time points due to marked heterogeneity, but it was associated with significant symptom severity reductions in subgroups of chronic, non-refractory schizophrenia patients after 6 weeks. The compound was well-tolerated.", "population_specificity": "Adult participants with schizophrenia, specifically chronic and non-refractory cases (without added clozapine).", "effective_dosage": "2 g/day, orally.", "study_duration": "2, 4, 6, or >6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:30.690926+00:00"}
{"study_id": 36608, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to determine whether sarcosine affects neuropeptide Y (NPY) levels and its association with symptom severity and metabolic parameters in schizophrenia patients with predominant negative symptoms.", "results_summary": "Sarcosine did not alter NPY levels but improved PANSS scores for negative symptoms and general psychopathology. The greatest NPY decrease occurred in initially depressed patients who became euthymic.", "population_specificity": "57 subjects with chronic schizophrenia, predominant negative symptoms, and stable antipsychotic treatment.", "effective_dosage": "2 g daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:31.702603+00:00"}
{"study_id": 36611, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and cognitive effects of sarcosine in treating schizophrenia through a meta-analysis of randomized controlled trials.", "results_summary": "Sarcosine showed significant improvement in overall clinical symptoms of schizophrenia but had a positive yet insignificant effect on cognitive functions. The benefits were more pronounced in patients with stable symptoms and those not on clozapine.", "population_specificity": "Patients diagnosed with schizophrenia according to DSM-IV criteria (n=326 across seven trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Add-on sarcosine combined with first- and second-generation antipsychotics (except clozapine) had a positive effect.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:33.917536+00:00"}
{"study_id": 36609, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antiepileptogenic effect of sarcosine (a GlyT1 inhibitor) and investigate its potential mechanisms, including GlyT1 expression and epigenetic changes in DNA methylation.", "results_summary": "Sarcosine (3 g/kg daily) suppressed epileptogenesis in rats, reduced hippocampal GlyT1 expression, altered DNA methylation (decreased 5mC and increased 5hmC), and differentially affected TET1 and DNMTs expression. These findings suggest sarcosine has disease-modifying properties in epileptogenesis.", "population_specificity": "Rats in a modified rapid kindling model of epileptogenesis.", "effective_dosage": "3 g/kg, intraperitoneally, daily.", "study_duration": "Duration not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:34.186214+00:00"}
{"study_id": 36612, "supplement_id": 1537, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate lipopolysarcosine derivatives (BA-pSar) as an alternative surface modification strategy to PEGylation for nanoparticles, focusing on circulation longevity and reduced hypersensitivity risks.", "results_summary": "BA-pSar demonstrated excellent surface charge shielding, enhanced circulation properties, reduced macrophage recognition, and lowered complement activation compared to PEGylated liposomes, matching PEGylation benefits while potentially reducing its drawbacks.", "population_specificity": "Zebrafish model (preclinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:34.343256+00:00"}
{"study_id": 36610, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to synthesize and evaluate the efficacy and safety of a sarcosine-aniline hybrid drug for managing plasmodial infections, focusing on its potential as a new antimalarial agent.", "results_summary": "The sarcosine-aniline hybrid showed moderate efficacy with an IC50 of 44.80 ng/ml and an ED50 of 6.49 mg/kg, though less potent than standard drugs like artesunate and chloroquine. It was found to be safe, with low toxicity (CC50 of 50.18 \u03bcg/ml) and no significant adverse effects in mice.", "population_specificity": "Mice (in vivo) and vero cells (in vitro) were studied.", "effective_dosage": "ED50 of 6.49 mg/kg for the sarcosine-aniline hybrid.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:35.291263+00:00"}
{"study_id": 36613, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate Sarcosine's potential as a biologically rational treatment for schizophrenia by boosting NMDAR function.", "results_summary": "The abstract suggests some evidence for Sarcosine's efficacy in schizophrenia, though the number of studies is small. Psychiatrists could consider its use based on available data.", "population_specificity": "Patients with schizophrenia (implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:35.799523+00:00"}
{"study_id": 36615, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether post-treatment urinary sarcosine levels are associated with prostate cancer relapse.", "results_summary": "Elevated urinary sarcosine levels were significantly associated with increased relapse rates, particularly in patients with levels \u2265200 nmol/L. Sarcosine was an independent predictor of recurrent relapses, especially in those who underwent radical prostatectomy.", "population_specificity": "511 patients with prostate cancer, including various risk factors and treatment strategies.", "effective_dosage": "Not specified (measured urinary sarcosine levels, not administered dosage).", "study_duration": "Median follow-up of 53 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:40.138302+00:00"}
{"study_id": 36614, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review and compare various methods for the quantitative analysis of sarcosine, with a focus on biosensor strategies and their analytical performance.", "results_summary": "The study found that sarcosine biosensors operate optimally at pH 7.0-8.0, detect sarcosine in a linear range of 0.1-100 \u03bcM within 2-17 seconds, and have a stability period of 3-180 days. Elevated sarcosine levels are linked to several diseases, including prostate cancer, Alzheimer's, and sarcosinemia.", "population_specificity": "Not specified (review of analytical methods, not a clinical trial).", "effective_dosage": "Not applicable (methodological review).", "study_duration": "Not applicable (methodological review).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:40.751811+00:00"}
{"study_id": 36616, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sarcosine improves schizophrenia symptoms and whether initial TNF-alpha levels predict symptom improvement.", "results_summary": "Sarcosine significantly improved negative symptoms, general psychopathology, and total PANSS scores but did not affect TNF-alpha levels. TNF-alpha levels correlated with depressive symptoms in the placebo group but not with sarcosine's effects.", "population_specificity": "Sixty subjects with stable schizophrenia.", "effective_dosage": "2 g of sarcosine daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:41.660500+00:00"}
{"study_id": 36617, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether sarcosine supplementation affects IL-6 levels and symptom severity in schizophrenia patients with predominantly negative symptoms.", "results_summary": "Sarcosine improved negative symptoms and general psychopathology but did not affect IL-6 levels. Initial IL-6 levels correlated with positive symptom severity, and IL-6 reduction was negatively associated with positive symptom improvement.", "population_specificity": "58 individuals with schizophrenia and predominantly negative symptoms.", "effective_dosage": "2 g daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:41.862506+00:00"}
{"study_id": 36618, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of sarcosine on prostate cancer cell proliferation and tumor growth, focusing on its role in cancer progression.", "results_summary": "Sarcosine stimulated proliferation of both androgen-independent and androgen-dependent prostate cancer cells in vitro and in murine xenografts, increasing tumor growth and altering gene expression related to cell cycle progression.", "population_specificity": "Metastatic prostate cancer cells (PC-3 and LNCaP) and murine xenografts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:42.413799+00:00"}
{"study_id": 36619, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of sarcosine as an oncometabolite in prostate cancer (PCa) and assess the potential of folate-targeted liposomes (antisarAbs@LIP and sar@LIP) as anticancer strategies.", "results_summary": "Sar@LIP treatment increased tumor volume and weight, while antisarAbs@LIP showed a mild antitumor effect. Sarcosine-related changes in gene expression, zinc ions, and metallothioneins were observed, suggesting its role in PCa progression.", "population_specificity": "Mice with PC-3 xenografts (prostate cancer model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:44.583273+00:00"}
{"study_id": 36620, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of long-term sarcosine treatment on depression-like behavior, mTOR signaling, and AMPAR membrane insertion in rats, comparing naive rats and those exposed to chronic unpredictable stress (CUS).", "results_summary": "Long-term sarcosine treatment (560mg/kg/d for 21 days) significantly reduced immobility in CUS-exposed rats in the forced swim test, indicating antidepressant-like effects, but had no effect in naive rats. The treatment increased mTOR activation and AMPAR membrane insertion in both groups, but these changes did not correlate with behavioral responses.", "population_specificity": "Rats (naive and those exposed to chronic unpredictable stress).", "effective_dosage": "560mg/kg per day.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:45.504969+00:00"}
{"study_id": 36622, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine changes in MMP-9 levels during sarcosine augmentation of antipsychotic treatment and assess its relationship with schizophrenia symptom severity.", "results_summary": "Sarcosine improved negative symptoms, general psychopathology, and total PANSS scores compared to placebo, but no correlation was found between MMP-9 levels and symptom improvement. MMP-9 levels remained stable in both groups.", "population_specificity": "58 patients with schizophrenia and predominant negative symptoms.", "effective_dosage": "2 grams daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:49.177842+00:00"}
{"study_id": 36621, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy of sarcosine in treating children with ADHD, particularly its impact on inattention, hyperactivity/impulsivity, and oppositional defiant disorder (ODD) symptoms.", "results_summary": "Sarcosine marginally surpassed placebo in reducing ODD symptoms at weeks 2, 4, and 6, but showed no significant effects on inattention or hyperactivity/impulsivity. The treatment was well tolerated, suggesting potential as a novel agent for managing ODD symptoms in ADHD.", "population_specificity": "116 children with ADHD.", "effective_dosage": "0.03 g/kg/day.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:49.483271+00:00"}
{"study_id": 36623, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if BDNF levels correlate with schizophrenia symptom severity and whether sarcosine augmentation improves symptoms via NMDA-dependent mechanisms.", "results_summary": "Sarcosine improved negative symptoms, general psychopathology, and total PANSS scores compared to placebo, but no correlation was found between BDNF levels and symptom improvement. BDNF levels remained stable throughout the study.", "population_specificity": "57 individuals with schizophrenia and predominantly negative symptoms.", "effective_dosage": "2g daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:50.699297+00:00"}
{"study_id": 36624, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a sensitive and selective colorimetric nanocomposite platform for rapid detection of sarcosine in alkaline media.", "results_summary": "The study demonstrated that a graphene oxide (GO) nanocomposite functionalized with NQS provided a highly efficient, selective, and sensitive colorimetric response for sarcosine detection, achieving a low detection limit of 0.73 \u03bcM. The method also showed excellent selectivity against other amino acids and allowed verification of the sensing mechanism via electrochemical methods.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:52.315865+00:00"}
{"study_id": 36626, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining sarcosine and sodium benzoate would be more effective than sarcosine alone in improving cognitive and global functioning in schizophrenia patients.", "results_summary": "The study found that adjunctive sarcosine plus benzoate improved cognitive and global functioning in schizophrenia patients, even without symptom improvement, while sarcosine alone did not show these benefits.", "population_specificity": "Chronic schizophrenia patients", "effective_dosage": "2 g/day sarcosine, 1 g/day benzoate", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:52.841137+00:00"}
{"study_id": 36625, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sarcosine-related amino acids affect the aggressiveness (cell mobility and division rates) and GNMT expression in benign and malignant prostate cells.", "results_summary": "Sarcosine and glycine significantly increased migration in metastatic PC-3 cells, while sarcosine also accelerated cell division in 22Rv1 and PC-3 cells. Amino acid profiling revealed specific patterns linked to prostate cancer progression, with higher levels of serine, glutamic acid, and aspartate in PC-3 cells.", "population_specificity": "Prostate cell lines (PNT1A, 22Rv1, and PC-3).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:53.482999+00:00"}
{"study_id": 36627, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether sarcosine supplementation could modulate glutamatergic transmission and improve brain metabolite ratios and symptom scores in patients with schizophrenia.", "results_summary": "Sarcosine significantly decreased Glx/Cr and Glx/Cho ratios, increased NAA/Cr ratio, and improved PANSS scores in schizophrenia patients compared to placebo, supporting its role in mitigating glutamatergic overstimulation.", "population_specificity": "50 patients with stable schizophrenia (DSM-IV-TR) and dominant negative symptoms, receiving antipsychotic therapy.", "effective_dosage": "2 g daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:53.611894+00:00"}
{"study_id": 36629, "supplement_id": 1537, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine if sarcosine supplementation affects metabolic and body composition parameters in patients with schizophrenia over a 6-month period.", "results_summary": "The study found that sarcosine supplementation had no effect on cardiometabolic or body composition parameters in patients with schizophrenia. The results suggest metabolic safety but no therapeutic impact on the measured outcomes.", "population_specificity": "Patients with schizophrenia receiving ongoing antipsychotic treatment.", "effective_dosage": "2g of sarcosine daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:57.510887+00:00"}
{"study_id": 36628, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of a six-month sarcosine therapy on brain metabolite concentrations and clinical symptoms in patients with stable schizophrenia.", "results_summary": "Sarcosine significantly increased markers of neuronal viability (NAA) and neuroglial activity (mI) in the left DLPFC, with concurrent improvement in clinical symptoms, compared to placebo. The placebo group showed only a minor increase in NAA/Cr ratio.", "population_specificity": "Fifty patients with stable schizophrenia on constant antipsychotic doses.", "effective_dosage": "2 grams daily", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:57.849936+00:00"}
{"study_id": 36630, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effects of sarcosine on metabolic parameters in the left hippocampus and its potential to modulate glutamatergic transmission in patients with schizophrenia.", "results_summary": "Sarcosine treatment led to a significant decrease in hippocampal Glx/Cr and Glx/Cho ratios, indicating reduced glutamatergic transmission, while other metabolic markers remained stable. The study suggests sarcosine may reverse pathological glutamatergic hyperactivity in schizophrenia.", "population_specificity": "Fifty patients diagnosed with schizophrenia (DSM-IV-TR), with dominant negative symptoms, in stable clinical condition and on stable antipsychotic doses.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:59.734084+00:00"}
{"study_id": 36631, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether sarcosine exerts antidepressant-like effects by enhancing the AMPAR-mTOR signaling pathway and facilitating AMPAR membrane insertion.", "results_summary": "A single injection of sarcosine exhibited rapid antidepressant-like effects in rats, activating the mTOR signaling pathway and increasing GluR1 phosphorylation at the PKA site, effects blocked by mTOR or AMPAR inhibitors.", "population_specificity": "Rats (rodent model)", "effective_dosage": "Single injection (specific dosage not provided)", "study_duration": "Acute (single administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:15:59.862296+00:00"}
{"study_id": 36633, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety, pharmacokinetics, and potential efficacy of sarcosine as an adjunct treatment for schizophrenia.", "results_summary": "Sarcosine showed significant improvement in positive symptoms and general psychopathology within one week, with trends in total symptom reduction and cognitive processing speed. It exhibited linear kinetics with a short half-life.", "population_specificity": "22 stabilized schizophrenia patients.", "effective_dosage": "2 gm/d (5 patients) and 4 gm/d (17 patients).", "study_duration": "Short-term (one week).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:01.268272+00:00"}
{"study_id": 36634, "supplement_id": 1537, "safety_score": "70", "efficacy_score": 80, "quality_score": 60, "study_goal": "The researchers aimed to investigate the effects of sarcosine on negative and cognitive symptoms in a schizophrenia patient and assess its interaction with existing antipsychotic and antidepressant treatment.", "results_summary": "Sarcosine improved the patient's activity and mood initially but later induced hypomania, which resolved after reducing venlafaxine dosage. The patient's mood and activity stabilized and remained better than baseline without subsequent depressive symptoms.", "population_specificity": "A 34-year-old woman with schizophrenia and persistent moderate negative and cognitive symptoms.", "effective_dosage": "2 g per day", "study_duration": "10 weeks", "interactions": "Interaction noted with venlafaxine, leading to hypomania.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:02.014060+00:00"}
{"study_id": 36632, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the interference of calcium dobesilate with creatinine quantification in sarcosine oxidase enzymatic (SOE) assays and assess its clinical significance.", "results_summary": "The study found that calcium dobesilate caused significant negative interference in all SOE-based creatinine assays, with reductions ranging from -4.4% to -60.5% depending on the assay and timing. The degree of interference varied widely among different commercially available assays.", "population_specificity": "Healthy participants (group I and II) and 10 patients treated with calcium dobesilate.", "effective_dosage": "Calcium dobesilate concentrations of 0, 2, 4, 8, 16, 32, and 64 \u03bcg/mL in vitro; oral administration in vivo (specific dosage not mentioned).", "study_duration": "Not specified (timing of measurements: 0, 2, and 3 hours post-administration).", "interactions": "Interference with creatinine quantification in SOE assays.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:03.861503+00:00"}
{"study_id": 36635, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate sarcosine's ability to predict pathological characteristics of prostate cancer in patients undergoing radical prostatectomy.", "results_summary": "Sarcosine levels were significantly higher in patients with aggressive prostate cancer features (tumor volume \u22650.5 ml, Gleason sum \u22657, and pT3 disease). It showed comparable predictive accuracy (AUC 0.85) for T3 stage prediction but was less consistent for other outcomes compared to phi.", "population_specificity": "78 patients with biopsy-proven prostate cancer undergoing radical prostatectomy at a high-volume institution.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:06.791363+00:00"}
{"study_id": 36636, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the inhibitory potency of novel N-substituted sarcosines on GlyT-1 activity and their potential to enhance extracellular glycine concentrations, with implications for treating neuropsychiatric disorders.", "results_summary": "Several synthesized sarcosine analogues demonstrated potent GlyT-1 inhibition and increased extracellular glycine levels in rat striatum, without inducing compulsive running behavior seen with NFPS. These inhibitors also reduced phencyclidine-induced hypermotility in mice, suggesting potential therapeutic benefits for NMDA receptor-related disorders.", "population_specificity": "Rat brain synaptosomal preparations and conscious rat striatum; mice for behavioral studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:07.176874+00:00"}
{"study_id": 36638, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate sarcosine's inhibitory effect on acrylamide formation in ripe olives and its impact on sensory characteristics.", "results_summary": "Sarcosine at 100 mM reduced acrylamide content in ripe olives with minimal effect on sensory qualities, likely through the Michael reaction mechanism.", "population_specificity": "Ripe olives (in vitro study, not human subjects).", "effective_dosage": "100 mM or 200 mM at equilibrium in packing solutions.", "study_duration": "Sterilization treatment at 121\u00b0C (duration not specified beyond heating for 30 min in model solution).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:08.490294+00:00"}
{"study_id": 36640, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sarcosine pre-treatment could induce ischemic tolerance in rat hippocampal slices exposed to oxygen/glucose deprivation (OGD).", "results_summary": "Sarcosine reduced cell death, glutamate release, LDH levels, NO production, and ROS in hippocampal slices exposed to OGD, demonstrating protective effects against ischemic insult. No changes were observed in antioxidant enzyme activities.", "population_specificity": "Rat hippocampal slices", "effective_dosage": "300 mg/kg per day, intraperitoneally", "study_duration": "Seven consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:09.607673+00:00"}
{"study_id": 36639, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a rapid and inexpensive procedure for quantifying sarcosine in urine using lentil plant peroxidase (LPP) to assess its potential as a biomarker for prostate cancer.", "results_summary": "The study demonstrated a highly selective and efficient enzymatic method for detecting sarcosine in urine, with a detection limit of around 5 \u00d7 10(-7) M. The procedure was noted for its simplicity, high-sample throughput, and suitability for routine clinical analysis.", "population_specificity": "Not specified (clinical laboratory setting, likely human urine samples).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:10.299252+00:00"}
{"study_id": 36637, "supplement_id": 1537, "safety_score": "70", "efficacy_score": 80, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the efficacy and safety of sarcosine as an adjunct treatment for negative and cognitive symptoms in a schizophrenia patient already on quetiapine and citalopram.", "results_summary": "Sarcosine initially improved activity and mood but later caused increased drive, irritability, and tension, which subsided after dose reduction. The study suggests a dose range of 1-2 g/day, starting at 2 g and reducing to 1 g if side effects occur.", "population_specificity": "A 23-year-old schizophrenic patient on quetiapine and citalopram.", "effective_dosage": "2 g/day initially, reduced to 1 g/day due to side effects.", "study_duration": "4 weeks (2 weeks at 2 g/day, followed by 2 weeks at 1 g/day).", "interactions": "Glutamate-serotonin interaction noted during concomitant use of sarcosine, citalopram, and quetiapine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:11.680447+00:00"}
{"study_id": 36641, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of GNMT in brain function and the antipsychotic effects of sarcosine in a mouse model of schizophrenia.", "results_summary": "The study found that GNMT deficiency led to lower sarcosine levels and neuropsychological abnormalities in mice, which were ameliorated by sarcosine or clozapine treatment. Dysregulation of genes involved in methionine metabolism, ErbB, and mTOR signaling pathways was also observed in GNMT-deficient mice.", "population_specificity": "Gnmt-/- mice (a model for schizophrenia) and liver-specific-human-GNMT transgenic mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:13.881815+00:00"}
{"study_id": 36642, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential benefit of sarcosine treatment in patients with obsessive-compulsive disorder (OCD), particularly its ability to enhance NMDA receptor-mediated glutamatergic neurotransmission.", "results_summary": "Sarcosine treatment resulted in a mean 19.8% reduction in Y-BOCS scores, with 32% of subjects achieving a >35% reduction. Drug-naive subjects showed more profound and sustained improvement, and sarcosine was well-tolerated with minimal adverse effects.", "population_specificity": "26 outpatients with OCD (YBOCS >16), including drug-naive subjects, those who discontinued serotonin reuptake inhibitors, and those receiving adjunctive treatment.", "effective_dosage": "500 to 2000 mg/d (flexible dosage schedule)", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:16.023519+00:00"}
{"study_id": 36643, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a rapid, sensitive urine test for sarcosine to aid in the early diagnosis of prostate cancer and identify aggressive tumors.", "results_summary": "The study developed a method using solid-phase microextraction and gas chromatography-triple quadrupole mass spectrometry to accurately quantify sarcosine in urine, achieving high sensitivity and precision with detection limits of 0.10 ng/ml and quantification limits of 0.16 ng/ml. The method was validated for concentrations of 70, 250, and 800 ng/ml, demonstrating its potential as a diagnostic tool for prostate cancer.", "population_specificity": "Not specified (urine samples analyzed, but patient demographics not detailed).", "effective_dosage": "Not specified (method validation used concentrations of 70, 250, and 800 ng/ml).", "study_duration": "Not specified (method development study, no intervention duration mentioned).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:17.845104+00:00"}
{"study_id": 36645, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sarcosine affects the seizure threshold in mice and assess its potential as a safe adjuvant treatment for schizophrenia.", "results_summary": "Sarcosine did not lower the seizure threshold in the PTZ test but significantly raised the threshold for electroconvulsions at higher doses (400 and 800 mg/kg), showing weak anticonvulsant properties. The study suggests sarcosine is safe for schizophrenia treatment without proconvulsant risk and may have potential in epilepsy treatment.", "population_specificity": "Mice (two different seizure models: PTZ infusion and maximal electroshock seizure threshold test).", "effective_dosage": "100, 200, 400, and 800 mg/kg (intraperitoneal).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:17.911304+00:00"}
{"study_id": 36646, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether sarcosine could ameliorate prepulse inhibition (PPI) deficits in mGluR5 knockout mice, a model relevant to schizophrenia.", "results_summary": "Sarcosine effectively ameliorated PPI deficits in mGluR5 knockout mice, suggesting its potential role in improving behavioral abnormalities linked to glutamatergic dysfunction. The results indicate that sarcosine's mechanism may involve NMDA receptor modulation rather than group II mGluR activation.", "population_specificity": "mGluR5 knockout mice (animal model for schizophrenia-related behavioral deficits)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:18.649515+00:00"}
{"study_id": 36647, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the evidence supporting GlyT1 inhibition as a strategy to enhance NMDA receptor function and its potential for treating schizophrenia and cognitive disorders.", "results_summary": "The abstract highlights that GlyT1 blockade may elevate synaptic glycine levels, potentially improving NMDA receptor function, and discusses ongoing pharmaceutical efforts to develop GlyT1 inhibitors for neuropsychiatric conditions.", "population_specificity": "Not specified (general review of preclinical and pharmaceutical research).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:18.658809+00:00"}
{"study_id": 36648, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the efficacy of sarcosine (a GlyT-1 antagonist) and D-serine (an NMDA/glycine site agonist) in improving symptoms of schizophrenia.", "results_summary": "Sarcosine significantly outperformed placebo in all outcome measures (PANSS total, SANS, QOL, GAF) and was more effective than D-serine, which showed no significant difference from placebo. All treatments were well tolerated.", "population_specificity": "60 patients with chronic schizophrenia.", "effective_dosage": "2 g/d.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:20.584968+00:00"}
{"study_id": 36649, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sarcosine has analgesic and anti-neuropathic effects by acting on glycine type 1 transporter at multiple central nervous system sites.", "results_summary": "Oral sarcosine reduced mechanical sensitivity in both injured and uninjured limbs in rats, with stronger effects on the injured limb. Intrathecal administration was more effective for the uninjured limb, while prefrontal cortex infusions acutely reduced sensitivity in the injured limb. Repeated oral treatment induced long-term anti-neuropathic effects that disappeared after cessation.", "population_specificity": "Rats with spared nerve injury (SNI)", "effective_dosage": "Not specified", "study_duration": "Repeated daily administration (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:22.710898+00:00"}
{"study_id": 36650, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether sarcosine acts as an NMDAR co-agonist at the glycine binding site and how its effects compare to glycine in terms of NMDAR function and physiological outcomes.", "results_summary": "Sarcosine was found to be an NMDAR co-agonist with less desensitization than glycine, leading to larger intracellular Ca(2+) rises and Ca(2+)-activated K(+) currents. Despite differences in deactivation, NMDAR-dependent neuronal death and bursting were similar between sarcosine and glycine.", "population_specificity": "Cultured embryonic mouse hippocampal neurons", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:25.286316+00:00"}
{"study_id": 36644, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sarcosine, an NMDA receptor agonist, could facilitate the extinction of cocaine-induced conditioned place preference (CPP) and suppress cocaine-associated memory.", "results_summary": "Sarcosine (600 mg/kg) diminished the expression of cocaine-induced CPP in a delay-onset manner but did not affect the storage or consolidation of the memory. It also showed no observable aversive effects or activity impairment at the tested dosage.", "population_specificity": "Animal model (study focused on cocaine-induced CPP in rodents).", "effective_dosage": "300 and 600 mg/kg/day.", "study_duration": "3 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:25.702293+00:00"}
{"study_id": 36651, "supplement_id": 1537, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sarcosine, as a primary antipsychotic agent, is effective for acutely symptomatic drug-free patients with schizophrenia.", "results_summary": "Patients receiving 2 g of sarcosine daily were more likely to respond, particularly antipsychotic-na\u00efve patients, but there was no significant dose x time interaction difference. Both doses were well tolerated with minimal side effects.", "population_specificity": "Acutely symptomatic drug-free patients with schizophrenia, including antipsychotic-na\u00efve patients.", "effective_dosage": "2 g or 1 g daily", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:25.841182+00:00"}
{"study_id": 36654, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to examine the effect of stress on the modulatory properties of sarcosine, a glycine reuptake inhibitor, in relation to NMDA receptor-mediated neurotransmission.", "results_summary": "Under stress conditions, sarcosine and d-serine interacted synergistically to reduce MK-801's ability to antagonize electrically precipitated tonic hindlimb extension, showing modulatory effects not apparent in non-stress conditions.", "population_specificity": "BALB/c mouse strain and \"stressed\" mice.", "effective_dosage": "Not available", "study_duration": "24 hours after stress", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:26.658566+00:00"}
{"study_id": 36653, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the involvement of spinal mu-opioid receptor subtypes in the antinociceptive effects of intrathecally administered TAPS, a sarcosine-containing peptide analog of dermorphin.", "results_summary": "Intrathecal TAPS produced dose-dependent antinociception in mice, mediated specifically by spinal mu1-opioid receptors, as evidenced by complete blockade with a mu1 antagonist but no effect from mu2 antagonists. In contrast, another opioid peptide's effects were attenuated by mu2 antagonists but not mu1 antagonists.", "population_specificity": "Mice (tail-flick test model)", "effective_dosage": "Not specified (dose-dependent effects noted)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:27.857738+00:00"}
{"study_id": 36655, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanism by which N-(cyclopropyl)glycine (CPG) inactivates monomeric sarcosine oxidase (MSOX) and characterize the resulting modified flavin structure.", "results_summary": "The study found that CPG acts as a mechanism-based inactivator of MSOX, forming a modified reduced flavin with a fused five-membered ring. The crystal structure revealed the specific modifications to the FAD cofactor, supporting a single electron transfer mechanism.", "population_specificity": "Not applicable (in vitro enzyme study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:29.134104+00:00"}
{"study_id": 36656, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether sarcosine, as an NMDA receptor-enhancing agent, is more effective than D-serine or placebo in treating acute exacerbation of schizophrenia when used adjunctively with risperidone.", "results_summary": "Sarcosine adjunctive treatment significantly reduced PANSS and SANS scores compared to both placebo and D-serine, demonstrating superior efficacy in improving general, cognitive, depressive, and negative symptoms of schizophrenia. It was particularly effective in reducing alogia and blunted affect.", "population_specificity": "65 schizophrenic inpatients with acute exacerbation in Taiwan.", "effective_dosage": "2 g/d", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:32.156685+00:00"}
{"study_id": 36657, "supplement_id": 1537, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sarcosine, as an adjunct to stable antipsychotic regimens, could improve symptoms in schizophrenic patients by enhancing N-methyl-D-aspartate receptor function.", "results_summary": "Sarcosine treatment significantly improved positive, negative, cognitive, and general psychiatric symptoms in schizophrenic patients, with similar benefits observed in risperidone-treated patients. It was well-tolerated with no significant side effects reported.", "population_specificity": "Thirty-eight schizophrenic patients, including 20 treated with risperidone.", "effective_dosage": "2 g/day", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:33.636106+00:00"}
{"study_id": 36660, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to develop assay systems for substrate-specific proteins involved in glycine, sarcosine, and betaine reductase activity, and to characterize the proteins involved in sarcosine metabolism.", "results_summary": "The study identified and purified specific protein subunits involved in sarcosine reductase activity, demonstrating that sarcosine could be covalently coupled to a 47-kDa protein. The presence of this protein was specific to sarcosine metabolism and absent in glycine-grown cells.", "population_specificity": "Eubacterium acidaminophilum (bacterial cells)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:35.056788+00:00"}
{"study_id": 36658, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to characterize the kinetic mechanisms of sarcosine oxidation by heterotetrameric sarcosine oxidase (TSOX), focusing on flavin reduction and C-H bond cleavage.", "results_summary": "The study found that TSOX reduction by sarcosine follows a hyperbolic dependence on concentration, with pH-dependent kinetics suggesting two ionizable groups. It also identified a ground-state quantum tunneling mechanism (VEGST) for C-H bond breakage during sarcosine oxidation.", "population_specificity": "Enzymatic study (Arthrobactor sp. 1-IN and Escherichia coli-expressed TSOX)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:35.151523+00:00"}
{"study_id": 36659, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to characterize the structural and functional properties of monomeric sarcosine oxidase (MSOX) and N-methyltryptophan oxidase (MTOX), focusing on their covalent flavin attachment sites.", "results_summary": "The study identified 8alpha-(S-cysteinyl)FAD as the covalent flavin in MSOX and MTOX, with Cys315 and Cys308 as the respective attachment sites. It also provided the first evidence that MTOX is a flavoprotein and highlighted conserved cysteine residues among homologous enzymes.", "population_specificity": "Bacterial enzymes (MSOX from Bacillus sp. B-0618 and MTOX from E. coli)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:35.636155+00:00"}
{"study_id": 36661, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of (1-Sar, 8-Ile) angiotensin II in treating oleic acid-induced pulmonary edema in sheep.", "results_summary": "The angiotensin II analogue improved oxygenation and reduced pulmonary vascular resistance, with the highest dose (2000 ng/kg/min) showing complete response. Lower doses (300 and 600 ng/kg/min) had partial efficacy, with 43% of animals not responding.", "population_specificity": "Sheep with oleic acid-induced pulmonary edema under general anesthesia and mechanical ventilation.", "effective_dosage": "300 ng/kg/min, 600 ng/kg/min, and 2000 ng/kg/min via continuous intravenous infusion.", "study_duration": "270 minutes (4.5 hours).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:37.431265+00:00"}
{"study_id": 36662, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to characterize the flavin-peptides of dimethylglycine dehydrogenase and sarcosine dehydrogenase in rat liver mitochondria, focusing on their covalent flavin linkage and amino acid sequences.", "results_summary": "The study identified that both enzymes contain histidylflavin at the N terminus, with specific amino acid sequences for their flavin-peptides. Spectral and chromatographic properties indicated conversion of FAD-peptides to FMN-peptides after nucleotide pyrophosphatase treatment.", "population_specificity": "Rat liver mitochondria", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:37.649802+00:00"}
{"study_id": 36663, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of specific amino acid residues (sulfhydryl groups and histidine) in the enzymatic activity of sarcosine oxidase.", "results_summary": "The study found that modification of two sulfhydryl groups and one histidyl residue led to complete loss of enzymatic activity, with acetate providing partial or complete protection against inactivation depending on the modifying agent. The modified histidine appears essential for enzyme activity and is likely near the flavin moiety.", "population_specificity": "Corynebacterium (bacterial enzyme study, not human)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Acetate (competitive inhibitor) protected against inactivation by iodoacetamide and diethylpyrocarbonate.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:41.521463+00:00"}
{"study_id": 36664, "supplement_id": 1537, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the diagnostic accuracy of (sarcosine-1, threonine-8) angiotensin II in predicting surgical outcomes for renovascular hypertension.", "results_summary": "The infusion test had an overall accuracy of 59%, with a high false negative rate (80%). Postoperatively, hypertension was cured in 13 patients, improved in 6, and unchanged in 3. The study suggests considering multiple factors rather than relying on a single test for accurate prediction.", "population_specificity": "22 patients with renovascular hypertension undergoing renal revascularization or nephrectomy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:16:42.274224+00:00"}
